Dr. E.R. (Rob) Heerdink

David de Wiedgebouw
Universiteitsweg 99
Kamer 1.09
3584 CG Utrecht

Dr. E.R. (Rob) Heerdink

Associate Professor
Pharmacoepi. and Clinical Pharmacol.
+31 6 24 209 496
e.r.heerdink@uu.nl

Publications

2023

Scholarly publications

Visscher, B. B., Heerdink, E. R., & Rademakers, J. (2023). Usability of an animated diabetes information tool for patients with different health literacy levels: a qualitative study. The International Journal of Pharmacy Practice, 31(1), 46-54. https://doi.org/10.1093/ijpp/riac098

2022

Scholarly publications

Dijkstra, N. E., Sino, C. G. M., Schoonhoven, L., Verdoorn, S., Bouvy, M. L., & Heerdink, E. R. (2022). Home care nurses’ perceptions about their role in interprofessional collaborative practice in clinical medication reviews. Journal of Interprofessional Education and Practice, 28, 1-8. Article 100526. https://doi.org/10.1016/j.xjep.2022.100526
Minjon, L., Aarts, J. W., van den Ban, E., Egberts, T. C., & Heerdink, E. R. (2022). Clarity and applicability of adverse drug reaction-related monitoring instructions in clinical practice guidelines for children and adolescents treated with antipsychotic drugs: a review of six clinical practice guidelines. BMJ Open, 12(3), 1-9. Article e058940. https://doi.org/10.1136/bmjopen-2021-058940
Groenwold, R. H. H., Heerdink, E. R., & Klungel, O. H. (2022). Challenges in the Design, Registration, and Reporting of Noninferiority Trials. JAMA Psychiatry, 79(3), 191-192. Advance online publication. https://doi.org/10.1001/jamapsychiatry.2021.3932
Smale, E. M., Egberts, T. C. G., Heerdink, E. R., van den Bemt, B. J. F., & Bekker, C. L. (2022). Key factors underlying the willingness of patients with cancer to participate in medication redispensing. Research in Social and Administrative Pharmacy, 18(8), 3329-3337. Advance online publication. https://doi.org/10.1016/j.sapharm.2021.12.004
Minjon, L., van den Ban, E., Bazelier, M. T., Lalmohamed, A., Egberts, T. C. G., & Heerdink, E. R. (2022). Monitoring of Adverse Drug Reaction-Related Parameters in Children, Youth, and Young Adults Prescribed Antipsychotic Drugs by General Practitioners. Journal of Child and Adolescent Psychopharmacology, 32(1), 36-44. Advance online publication. https://doi.org/10.1089/cap.2021.0026
Dijkstra, N. E., Sino, C. G. M., Schuurmans, M. J., Schoonhoven, L., & Heerdink, E. R. (2022). Medication self-management: Considerations and decisions by older people living at home. Research in Social and Administrative Pharmacy, 18(3), 2410-2423. https://doi.org/10.1016/j.sapharm.2020.09.004

2021

Scholarly publications

Beex-Oosterhuis, M. M., Van Gool, A. R., Heerdink, E. R., van Kesteren, C., & van Marum, R. J. (2021). Clozapine Treatment During Pregnancy and the Postpartum Period: A Systematic Literature Review. Journal of Clinical Psychiatry, 83(1), Article 38713. https://doi.org/10.4088/JCP.21r13952
Visscher, B. B., Vervloet, M., Te Paske, R., van Dijk, L., Heerdink, E. R., & Rademakers, J. (2021). Implementation of an animated medication information tool in community pharmacies, with a special focus on patients with limited health literacy. The International Journal of Pharmacy Practice, 29(6), 566-572. https://doi.org/10.1093/ijpp/riab038
Dijkstra, N. E., Vervloet, M., Sino, C. G. M., Heerdink, E. R., Nelissen-Vrancken, M., Bleijenberg, N., de Bruin, M., & Schoonhoven, L. (2021). Home care patients’ experiences with home care nurses’ support in medication adherence. Patient Preference and Adherence, 2021(15), 1929-1940. https://doi.org/10.2147/PPA.S302818
Abdullah-Koolmees, H., Nawzad, S., Egberts, T. C. G., Vuyk, J., Gardarsdottir, H., & Heerdink, E. R. (2021). The effect of non-adherence to antipsychotic treatment on rehospitalization in patients with psychotic disorders. Therapeutic Advances in Psychopharmacology, 11, 1-12. https://doi.org/10.1177/20451253211027449
Vehof, H., Heerdink, E. R., Sanders, J., & Das, E. (2021). They promised this ten years ago. Effects of diabetes news characteristics on patients' perceptions and attitudes towards medical innovations and therapy adherence. PLoS One, 16(8), 1-16. Article e0255587. https://doi.org/10.1371/journal.pone.0255587
Visscher, B. B., Steunenberg, B., Zwikker, H., Heerdink, E. R., & Rademakers, J. (2021). The impact of health literacy on beliefs about medication in a Dutch medication-using population. European Journal of Clinical Pharmacology, 77(8), 1219-1224. https://doi.org/10.1007/s00228-021-03105-0
Smale, E. M., Egberts, T. C. G., Heerdink, E. R., van den Bemt, B. J. F., & Bekker, C. L. (2021). Waste-minimising measures to achieve sustainable supply and use of medication. Sustainable Chemistry and Pharmacy, 20, 1-7. Article 100400. https://doi.org/10.1016/j.scp.2021.100400
Minjon, L., Brozina, I., Egberts, T. C. G., Heerdink, E. R., & van den Ban, E. (2021). Monitoring of Adverse Drug Reaction-Related Parameters in Children and Adolescents Treated With Antipsychotic Drugs in Psychiatric Outpatient Clinics. Frontiers in Psychiatry, 12, Article 640377. https://doi.org/10.3389/fpsyt.2021.640377

Professional publications

Bouvy, M., Heerdink, R., & Koster, E. (2021). Apothekers geloven in effectiviteit en veiligheid van COVID-19-vaccins: Peiling: vaccinatiebereidheid onder apothekersassistenten blijft achter. Pharmaceutisch Weekblad, 156(7), 14-15. https://www.pw.nl/achtergrond/2021/apothekers-geloven-in-effectiviteit-en-veiligheid-van-covid-19-vaccins

2020

Scholarly publications

Komen, J. J., Heerdink, E. R., Klungel, O. H., Mantel-Teeuwisse, A. K., Forslund, T., Wettermark, B., & Hjemdahl, P. (2020). Long-term persistence and adherence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk. European heart journal. Cardiovascular pharmacotherapy, 7(FI1), f72-f80. https://doi.org/10.1093/ehjcvp/pvaa017
du Pon, E., Kleefstra, N., Cleveringa, F., van Dooren, A., Heerdink, E. R., & van Dulmen, S. (2020). Effects of the Proactive Interdisciplinary Self-Management (PRISMA) Program on Online Care Platform Usage in Patients with Type 2 Diabetes in Primary Care: A Randomized Controlled Trial. Journal of Diabetes Research, 2020, Article 5013142. https://doi.org/10.1155/2020/5013142
Visscher, B. B., Steunenberg, B., Heerdink, E. R., & Rademakers, J. (2020). Medication self-management support for people with diabetes and low health literacy: A needs assessment. PLoS One, 15(4), Article e0232022. https://doi.org/10.1371/journal.pone.0232022
Krediet, E., Janssen, D. G., Heerdink, E. R., Egberts, T. C., & Vermetten, E. (2020). Experiences with medical cannabis in the treatment of veterans with PTSD: Results from a focus group discussion. European Neuropsychopharmacology, 36, 244-254. https://doi.org/10.1016/j.euroneuro.2020.04.009
Janssen, D. G. A., Jonker, J., van Dijk, D., Heerdink, E. R., Egberts, T. C. G., & Slooter, A. J. C. (2020). Psychotropic medication use in former ICU patients with mental health problems: A prospective observational follow-up study. Journal of Critical Care, 59, 112-117. Advance online publication. https://doi.org/10.1016/j.jcrc.2020.06.002
Beex-Oosterhuis, M. M., Samb, A., Heerdink, E. R., Souverein, P. C., Van Gool, A. R., Meyboom, R. H. B., & van Marum, R. J. (2020). Safety of clozapine use during pregnancy: Analysis of international pharmacovigilance data. Pharmacoepidemiology and Drug Safety, 29(6), 725-735. https://doi.org/10.1002/pds.5016
Man, W. H., Wilting, I., Souverein, P., Meyboom, R., Egberts, T., & Heerdink, E. R. (2020). Reporting Patterns of Sialorrhea Comparing Users of Clozapine to Users of Other Antipsychotics: A Disproportionality Analysis Using VigiBase. Journal of Clinical Psychopharmacology, 40(3), 283-286. https://doi.org/10.1097/JCP.0000000000001198

2019

Scholarly publications

du Pon, E., El Azzati, S., van Dooren, A., Kleefstra, N., Heerdink, E., & van Dulmen, S. (2019). Effects of a Proactive Interdisciplinary Self-Management (PRISMA) program on medication adherence in patients with type 2 diabetes in primary care: a randomized controlled trial. Patient Preference and Adherence, 13, 749-759. https://doi.org/10.2147/PPA.S188703
Vehof, H., Heerdink, E., Sanders, J., & Das, E. (2019). Associations Between Characteristics of Web-Based Diabetes News and Readers' Sentiments: Observational Study in the Netherlands. Journal of Medical Internet Research, 21(11), Article e14554. https://doi.org/10.2196/14554
du Pon, E., Kleefstra, N., Cleveringa, F., van Dooren, A., Heerdink, E. R., & van Dulmen, S. (2019). Effects of the Proactive interdisciplinary self-management (PRISMA) program on self-reported and clinical outcomes in type 2 diabetes: a pragmatic randomized controlled trial. BMC Endocrine Disorders, 19(1), 139. https://doi.org/10.1186/s12902-019-0466-0
Janssen, D. G. A., Vermetten, E., Egberts, T. C. G., & Heerdink, E. R. (2019). Discontinuation Rates of Antidepressant Use by Dutch Soldiers. Pain Medicine, 184(11-12), 868-874. https://doi.org/10.1093/milmed/usz060
Stoker, L. J., Heerdink, E. R., Janssen, R., & Egberts, T. C. G. (2019). Effect of reimbursement restriction policy on the use of benzodiazepines in the Netherlands: an interrupted time series analysis. BMJ Open, 9, Article e029148. https://doi.org/10.1136/bmjopen-2019-029148
Man, W. H., Wilting, I., Heerdink, E. R., Hugenholtz, G. W. K., Bognár, T., Ten Berg, M. J., van Solinge, W. W., Egberts, T. C. G., & van Maarseveen, E. M. (2019). Unbound Fraction of Clozapine Significantly Decreases with Elevated Plasma Concentrations of the Inflammatory Acute-Phase Protein Alpha-1-Acid Glycoprotein. Clinical Pharmacokinetics, 58(8), 1069-1075. https://doi.org/10.1007/s40262-019-00744-6
Minjon, L., van den Ban, E., de Jong, E., Souverein, P. C., Egberts, T. C. G., & Heerdink, E. R. (2019). Reported Adverse Drug Reactions in Children and Adolescents Treated with Antipsychotics. Journal of Child and Adolescent Psychopharmacology, 29(2), 124-132. https://doi.org/10.1089/cap.2018.0139
Nederlof, M., Egberts, T. C. G., van Londen, L., de Rotte, M. C. F. J., Souverein, P. C., Herings, R. C. M., & Heerdink, E. R. (2019). Compliance with the guidelines for laboratory monitoring of patients treated with lithium: a retrospective follow-up study among ambulatory patients in the Netherlands. Bipolar Disorders, 21(5), 419-427. https://doi.org/10.1111/bdi.12730

2018

Scholarly publications

Beex-Oosterhuis, M. M., Heerdink, E. R. R., Van Gool, A. R., & Van Marum, R. J. (2018). Predicting unsuccessful clozapine treatment after first use in adult patients with psychotic disorders. Journal of Clinical Psychopharmacology, 38(6), 604-608. https://doi.org/10.1097/JCP.0000000000000977
Nederlof, M., Cath, D. C., Stoker, L. J., Egberts, A. C. G., & Heerdink, E. R. (2018). Begeleiding door artsen en apothekers tijdens antidepressivagebruik: behoeften van patienten en suggesties ter verbetering. Pharmaceutisch Weekblad, 153(46), 25-27.
https://dspace.library.uu.nl/bitstream/handle/1874/428382/a1682.pdf?sequence=1
Dijkstra, N. E., Sino, C. G. M., Heerdink, E. R., & Schuurmans, M. J. (2018). Development of eHOME, a Mobile Instrument for Reporting, Monitoring, and Consulting Drug-Related Problems in Home Care: Human-Centered Design Study. JMIR Human Factors, 5(1), 1-9. Article e10. https://doi.org/10.2196/humanfactors.8319
de Hoop, B., Heerdink, E. R., & Hazekamp, A. (2018). Medicinal Cannabis on Prescription in The Netherlands: Statistics for 2003-2016. Cannabis and Cannabinoid Research, 3(1), 54-55. https://doi.org/10.1089/can.2017.0059
Vehof, H., Sanders, J., van Dooren, A., Heerdink, E., & Das, E. (2018). Clinical evidence vs preliminary speculation in newspaper coverage of diabetes innovations: a quantitative analysis. Public Health, 160, 49-51. https://doi.org/10.1016/j.puhe.2018.03.022
van Strien, A. M., Souverein, P. C., Keijsers, C. J. P. W., Heerdink, E. R., Derijks, H. J., & van Marum, R. J. (2018). Association Between Urinary Tract Infections and Antipsychotic Drug Use in Older Adults. Journal of Clinical Psychopharmacology, 38(4), 296-301. https://doi.org/10.1097/JCP.0000000000000895
Termorshuizen, F., Heerdink, E. R., & Selten, J-P. (2018). The impact of ethnic density on dispensing of antipsychotic and antidepressant medication among immigrants in the Netherlands. Social Science and Medicine, 211, 87-94. https://doi.org/10.1016/j.socscimed.2018.06.005
Man, W. H., Pérez-Pitarch, A., Wilting, I., Heerdink, E. R., van Solinge, W. W., Egberts, A. C. G., & Huitema, A. D. R. (2018). Development of a nomogram for the estimation of long-term adherence to clozapine therapy using neutrophil fluorescence. British Journal of Clinical Pharmacology, 84(6), 1228-1237. https://doi.org/10.1111/bcp.13546
van Keulen, K., Knol, W., Belitser, S. V., Zaal, I. J., van der Linden, P. D., Heerdink, E. R., Egberts, T. C. G., & Slooter, A. J. C. (2018). Glucose variability during delirium in diabetic and non-diabetic intensive care unit patients: A prospective cohort study. PLoS One, 13(11), Article 0205637. https://doi.org/10.1371/journal.pone.0205637
van Keulen, K., Knol, W., Belitser, S. V., van der Linden, P. D., Heerdink, E. R., Egberts, T. C. G., & Slooter, A. J. C. (2018). Diabetes and Glucose Dysregulation and Transition to Delirium in ICU Patients. Critical Care Medicine, 46(9), 1444-1449. https://doi.org/10.1097/CCM.0000000000003285
Nederlof, M., Kupka, R. W., Braam, A. M., Egberts, A., & Heerdink, E. R. (2018). Evaluation of clarity of presentation and applicability of monitoring instructions for patients using lithium in clinical practice guidelines for treatment of bipolar disorder. Bipolar Disorders, 20(8), 708-720. https://doi.org/10.1111/bdi.12681
Minjon, L., van den Ban, E., de Jong, E., Egberts, T. C. G., & Heerdink, E. R. (2018). Monitoring of metabolic, cardiac, and endocrine indicators in youth treated with antipsychotics as reported by health care professionals. Journal of Clinical Psychopharmacology, 38(5), 489-493. https://doi.org/10.1097/JCP.0000000000000936
Abdullah-Koolmees, H., Gardarsdottir, H., Egberts, T. C. G., Minnema, L. A., Elmi, K., Stoker, L. J., Vuyk, J., Goedhard, L. E., & Heerdink, E. R. (2018). Predicting rehospitalization in patients treated with antipsychotics: a prospective observational study. Therapeutic Advances in Psychopharmacology, 8(8), 213-229. https://doi.org/10.1177/2045125318762373
Nederlof, M., Heerdink, E. R., Egberts, A. C. G., Wilting, I., Stoker, L. J., Hoekstra, R., & Kupka, R. W. (2018). Monitoring of patients treated with lithium for bipolar disorder: an international survey. International Journal of Bipolar Disorders, 6(1). https://doi.org/10.1186/s40345-018-0120-1
Dautzenberg, G., Nederlof, M., Beekman, A., Egberts, T., & Heerdink, E. R. (2018). Severe Cognitive Impairment Associated with a High Free but Therapeutic Total Concentration of Valproic Acid Due to Hypoalbuminemia in an Older Patient with Bipolar Disorder. Journal of Clinical Psychopharmacology, 38(3), 265-268. https://doi.org/10.1097/JCP.0000000000000872

Professional publications

Risselada, A. J., Heerdink, E. R., Gonera, R. K., Egberts, T. C. G., & Mulder, H. (2018). Associatie tussen HTR2C-polymorfismen en gewichtsverlies bij patiënten met obesitas. Pharmaceutisch Weekblad, 153(6), 22-26.
https://dspace.library.uu.nl/bitstream/handle/1874/428383/Associatie_tussen_HTR2C_polymorfismen_en_gewichtsverlies_bij_pati_nten_met_obesitas_NPFO.pdf?sequence=1

2017

Scholarly publications

van Strien, A. M., Souverein, P. C., Keijsers, C. K. J. P. W., Heerdink, E. R., Derijks, H. J. J., & Van Marum, R. J. (2017). Antipsychotic drug use associated with urinary tract infections in older women. Maturitas, 98, 46-50. https://doi.org/10.1016/j.maturitas.2017.01.009
Nederlof, M., Benschop, T. W., de Vries Feyens, C. A., & Heerdink, E. R. (2017). Clozapine re-exposure after dilated cardiomyopathy. BMJ Case Reports, 2017, Article 219652. https://doi.org/10.1136/bcr-2017-219652
Termorshuizen, F., Selten, J-P., & Heerdink, E. R. (2017). Dispensing of psychotropic medication among 400,000 immigrants in The Netherlands. Social Psychiatry, 52(8), 963-977. https://doi.org/10.1007/s00127-017-1405-x
de Weert-van Oene, G. H., Termorshuizen, F., Buwalda, V. J. A., & Heerdink, E. R. (2017). Somatic health care utilization by patients treated for substance use disorders. Drug and Alcohol Dependence, 178, 277-284. https://doi.org/10.1016/j.drugalcdep.2017.05.022
Man, W. H., Colen-de Koning, J. C. A., Schulte, P. F. J., Cahn, W., van Haelst, I. M. M., Heerdink, R., & Wilting, I. (2017). Clozapine-induced hypersalivation: the association between quantification, perceived burden and treatment satisfaction reported by patients. Therapeutic Advances in Psychopharmacology, 7(8-9), 209-210. https://doi.org/10.1177/2045125317707746
Nederlof, M., Cath, D. C., Stoker, L. J., Egberts, T. C. G., & Heerdink, E. R. (2017). Guidance by physicians and pharmacists during antidepressant therapy: patients' needs and suggestions for improvement. BMC Psychiatry, 17(1), Article 388. https://doi.org/10.1186/s12888-017-1522-9
Man, W. H., Colen-de Koning, J. C. A., Schulte, P. F. J., Cahn, W., van Haelst, I. M. M., Doodeman, H. J., Egberts, T. C. G., Heerdink, E. R., & Wilting, I. (2017). The Effect of Glycopyrrolate on Nocturnal Sialorrhea in Patients Using Clozapine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial. Journal of Clinical Psychopharmacology, 37(2), 155-161. https://doi.org/10.1097/JCP.0000000000000657
Janssen, D. G. A., Vermetten, E., Egberts, T. C. G., & Heerdink, E. R. (2017). Prevalence of Psychotropic Medication Use Among Dutch Military Personnel Between 2003 and 2012 and Its Comparison to the Dutch General Population. Pain Medicine, 182(1), e1584-e1588. https://doi.org/10.7205/MILMED-D-15-00397
Janssen, D. G. A., Vermetten, E., Egberts, T. C. G., & Heerdink, E. R. (2017). Prevalence of use of erectile dysfunction medication by Dutch military personnel between 2003 and 2012. International Journal of Impotence Research, 29, 54-65. https://doi.org/10.1038/ijir.2016.44

Professional publications

Kooij, M. J., Heerdink, E. R., van Dijk, C. E. M. J., van Geffen, E. C. G., Belitser, S., & Bouvy, M. L. (2017). Telefonische startbegeleiding door apothekers verbetert de therapietrouw: een cluster-gerandomiseerd onderzoek. Nederlands Platform voor Farmaceutisch Onderzoek, Article a1655. https://www.knmp.nl/resolveuid/739774e4c2594765824d8a59c1b65921
https://dspace.library.uu.nl/bitstream/handle/1874/418641/Telefonische_startbegeleiding_door_apothekers_verbetert_de_therapietrouw_een_cluster_gerandomiseerd_onderzoek_NPFO.pdf?sequence=1

2016

Scholarly publications

Scheifes, A., & Heerdink, R. (2016). Bijwerkingen bij mensen met beperking lastig te herkennen. Pharmaceutisch Weekblad, 151(21), 14-15.
Arnet, I., Kooij, M. J., Messerli, M., Hersberger, K. E., Heerdink, E. R., & Bouvy, M. (2016). Proposal of Standardization to Assess Adherence With Medication Records: Methodology Matters. Annals of Pharmacotherapy, 50(5), 360-368. https://doi.org/10.1177/1060028016634106
Termorshuizen, F., Smeets, H. M., Boks, M. P., & Heerdink, E. R. (2016). Comparing episodes of antidepressants use with intermittent episodes of no use: A higher relative risk of suicide attempts but not of suicide at young age. Journal of Psychopharmacology, 30(10), 1000-1007. https://doi.org/10.1177/0269881116639752
Kooij, M. J., Heerdink, E. R., van Dijk, L., van Geffen, E. C., Belitser, S. V., & Bouvy, M. L. (2016). Effects of Telephone Counseling Intervention by Pharmacists (TelCIP) on Medication Adherence: Results of a Cluster Randomized Trial. Frontiers in Pharmacology, 7, Article 269. https://doi.org/10.3389/fphar.2016.00269
Abdullah, H., Gardarsdottir, H., Yazir, D., Stoker, L. J., Vuyk, J., Egberts, T. C. G., & Heerdink, E. R. (2016). Zorgen om medicatiegebruik psychiatrische patient na ontslag: Bijna 70% patiënten stopt met een of meer geneesmiddelen. Pharmaceutisch Weekblad, 151(7), 14-15. https://www.pw.nl/achtergrond/2016/zorgen-om-medicatiegebruik-psychiatrische-patient-na-ontslag
https://dspace.library.uu.nl/bitstream/handle/1874/428405/2016_Abdullah_Zorgen_medicatiegebruik_ontslag_psychiatrie_PW.pdf?sequence=1
Nederlof, M., Stoker, L., Egberts, T., & Heerdink, R. (2016). Instructies voor monitoren van klinische parameters in de registratieteksten van psychofarmaca: Overzicht en toepasbaarheid voor de klinische praktijk. Tijdschrift voor Psychiatrie, 58(8), 593-598.
https://dspace.library.uu.nl/bitstream/handle/1874/418633/58_2016_8_artikel_nederlof.pdf?sequence=1
Wouters, H., Amin, D. F. H., Taxis, K., Heerdink, E. R., Egberts, A. C. G., & Gardarsdottir, H. (2016). Associations between personality traits and adherence to antidepressants assessed through self-report, electronic monitoring, and pharmacy dispensing data: A Pilot Study. Journal of Clinical Psychopharmacology, 36(5), 465-471. https://doi.org/10.1097/JCP.0000000000000541
Nederlof, M., Frederix, G. W. J., Stoker, L. J., van Solinge, W. W., Egberts, T. C. G., & Heerdink, E. R. (2016). Patient monitoring: the hidden costs of antipsychotic treatment. British Journal of Clinical Pharmacology, 82(2), 570-572. https://doi.org/10.1111/bcp.12982
Scheifes, A., Walraven, S., Stolker, J. J., Nijman, H. L. I., Tenback, D. E., Egberts, T. C. G., & Heerdink, E. R. (2016). Movement Disorders in Adults With Intellectual Disability and Behavioral Problems Associated With Use of Antipsychotics. Journal of Clinical Psychopharmacology, 36(4), 308-313. Advance online publication. https://doi.org/10.1097/JCP.0000000000000528
Scheifes, A., Egberts, T. C. G., Stolker, J. J., Nijman, H. L. I., & Heerdink, E. R. (2016). Structured medication review to improve pharmacotherapy in people with intellectual disability and behavioural problems. Journal of Applied Research in Intellectual Disabilities, 29(4), 346–355. https://doi.org/10.1111/jar.12183
Scheifes, A., Walraven, S., Stolker, J. J., Nijman, H. L. I., Egberts, T. C. G., & Heerdink, E. R. (2016). Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs. Research in Developmental Disabilities, 49-50, 13-21. https://doi.org/10.1016/j.ridd.2015.11.017
Termorshuizen, F., Palmen, S. J., & Heerdink, E. R. (2016). Suicide Behavior Before and After the Start with Antidepressants: A High Persistent Risk in the First Month of Treatment Among the Young. International Journal of Neuropsychopharmacology, 19(2), 1-10. https://doi.org/10.1093/ijnp/pyv081

2015

Scholarly publications

Van Keulen, K., Van Der Linden, P. D., Souverein, P. C., Heerdink, E. R., Egberts, A. C. G., & Knol, W. (2015). Risk of Hospitalization for Hypoglycemia in Older Patients with Diabetes Using Antipsychotic Drugs. American Journal of Geriatric Psychiatry, 23(11), 1144-1153. https://doi.org/10.1016/j.jagp.2015.04.006
https://dspace.library.uu.nl/bitstream/handle/1874/428406/2015_van_Keulen_risk_hospitalization_hypoglycaemia_Am_J_Ger_Psych.pdf?sequence=1
Van Keulen, K., Van Der Linden, P. D., Souverein, P. C., Heerdink, E. R., Egberts, A. C. G., & Knol, W. (2015). Associatie tussen antipsychoticagebruik en hypoglykemie bij oudere patiënten met diabetes mellitus. Pharmaceutisch Weekblad, 150(16), 88-92.
https://dspace.library.uu.nl/bitstream/handle/1874/329748/2015wp0088_1_.pdf?sequence=1
de Haan, L., Egberts, A. C. G., & Heerdink, E. R. (2015). The relation between risk-taking behavior and alcohol use in young adults is different for men and women. Drug and Alcohol Dependence, 155, 222-227. Article 5706. https://doi.org/10.1016/j.drugalcdep.2015.07.013
Colen-De Koning, J. C. A., Man, W. H., Wilting, I., Schulte, P. F. J., Doodeman, H. J., Cahn, W., Heerdink, E. R., Egberts, A. C. G., & Van Haelst, I. M. M. (2015). Effect van glycopyrroniumbromide op nachtelijk clozapinegeïnduceerd speekselverlies bij patiënten met een psychiatrische aandoening. Pharmaceutisch Weekblad, 150(43), 219-222.
https://dspace.library.uu.nl/bitstream/handle/1874/327766/glycopyrroniumbromide.pdf?sequence=1
van den Ban, E. F., Souverein, P. C., van Engeland, H., Swaab, H., Egberts, T. C. G., & Heerdink, E. R. (2015). Differences in ADHD medication usage patterns in children and adolescents from different cultural backgrounds in the Netherlands. Social Psychiatry and Psychiatric Epidemiology, 50(7), 1153-1162. https://doi.org/10.1007/s00127-015-1068-4
Einarson, A., Egberts, T. C., & Heerdink, E. R. (2015). Antidepressant use in pregnancy: knowledge transfer and translation of research findings. Journal of Evaluation in Clinical Practice, 21(4), 579-83. https://doi.org/10.1111/jep.12338
Abdullah, H., Gardarsdottir, H., Yazir, D., Stoker, L. J., Vuyk, J., Egberts, T. C. G., & Heerdink, E. R. (2015). Medication Discontinuation in Patients After Discharge From a Psychiatric Hospital. Annals of Pharmacotherapy, 49(10), 1085-95. https://doi.org/10.1177/1060028015593763
Nederlof, M., Stoker, L. J., Egberts, T. C., & Heerdink, E. R. (2015). Instructions for clinical and biomarker monitoring in the Summary of Product Characteristics (SmPC) for psychotropic drugs: Overview and applicability in clinical practice. Journal of Psychopharmacology, 29(12), 1248-54. https://doi.org/10.1177/0269881115609016
Koster, E. S., de Haan, L., Bouvy, M. L., & Heerdink, E. R. (2015). Nonmedical Use of Attention-Deficit/Hyperactivity Disorder Medication Among Secondary School Students in The Netherlands. Journal of Child and Adolescent Psychopharmacology, 25(8), 649-652. https://doi.org/10.1089/cap.2015.0099
Kooy, M. J., Van Geffen, E. C. G., Heerdink, E. R., Van Dijk, L., & Bouvy, M. L. (2015). Patients' general satisfaction with telephone counseling by pharmacists and effects on satisfaction with information and beliefs about medicines: Results from a cluster randomized trial. Patient Education and Counseling, 98(6), 797-804. https://doi.org/10.1016/j.pec.2015.02.020
Hromadkova, L., Heerdink, E. R., Philbert, D., & Bouvy, M. L. (2015). Association between concomitant psychiatric drug use, and patients' beliefs about and persistence with chronic cardiovascular medication. International Journal of Clinical Practice, 69(3), 328-335. Advance online publication. https://doi.org/10.1111/ijcp.12544

2014

Scholarly publications

van den Ban, E., Souverein, P., Meijer, W., van Engeland, H., Swaab, H., Egberts, T., & Heerdink, R. (2014). Association between ADHD drug use and injuries among children and adolescents. European child & adolescent psychiatry, 23(2), 95-102. https://doi.org/10.1007/s00787-013-0432-8
Gardarsdottir, H., Stoker, L. J., Vuyk, J., Egberts, T. C. G., Heerdink, E. R., & Abdullah, H. (2014). Discontinuation of somatic medication during psychiatric hospitalization. Annals of Pharmacotherapy, 48(11), 1415-24. https://doi.org/10.1177/1060028014544897
Risselada, A. J., Mulder, H., Heerdink, E. R., Gregoor, J. G., Gonera, R. K., & Egberts, T. C. G. (2014). Combined HTR2C-LEP and HTR2C-LEPR genotypes as a determinant for obesity in patients without antipsychotic drugs. Journal of Clinical Psychopharmacology, 34(2), 266-268. https://doi.org/10.1097/JCP.0000000000000069
Lapeyre-Mestre, M., Gony, M., Carvajal, A., Macias, D., Conforti, A., D'incau, P., Heerdink, R., Van Der Stichele, R., & Bergman, U. (2014). A European community pharmacy-based survey to investigate patterns of prescription fraud through identification of falsified prescriptions. European Addiction Research, 20(4), 174-182. https://doi.org/10.1159/000356812
Koster, E. S., Heerdink, E. R., de Vries, T. W., & Bouvy, M. L. (2014). Attitudes towards medication use in a general population of adolescents. European Journal of Pediatrics, 173(4), 483-8.
Kooy, M. J., van Geffen, E. C. G., Heerdink, E. R., van Dijk, C. E. M. J., & Bouvy, M. L. (2014). Effects of a TELephone Counselling Intervention by Pharmacist (TelCIP) on medication adherence, patient beliefs and satisfaction with information for patients starting treatment: study protocol for a cluster randomized controlled trial. BMC Health Services Research, 14, 219.
Kleijer, B. C., van Marum, R. J., Frijters, D. H. M., Jansen, P. A. F., Ribbe, M. W., Egberts, A. C. G., & Heerdink, E. R. (2014). Variability between nursing homes in prevalence of antipsychotic use in patients with dementia. International Psychogeriatrics, 26(3), 363-71.

2013

Scholarly publications

Kooij, M., Van Wijk, B. L. G., Heerdink, E. R., De Boer, A., & Bouvy, M. L. (2013). Does the use of an electronic reminder device with or without counseling improve adherence to lipid-lowering treatment? The results of a randomized controlled trial. Frontiers in Pharmacology, 4 MAY. https://doi.org/10.3389/fphar.2013.00069
Thengilsdottir, G., Gardarsdottir, H., Almarsdottir, A. B., McClure, C. B., & Heerdink, E. R. (2013). The association between lifting an administrative restriction on antidepressant dispensing and treatment patterns in Iceland. Health Policy, 111(2), 193-199. https://doi.org/10.1016/j.healthpol.2013.03.002
Tenback, D. E., Van Kessel, F., Jessurun, J., Pijl, Y. J., Heerdink, E. R., & Van Harten, P. N. (2013). Risicofactoren voor inactiviteit bij patiënten met ernstige psychiatrische aandoeningen in de langdurige zorg. Tijdschrift voor Psychiatrie, 55(2), 83-91.
Abdullah-Koolmees, H., Gardarsdottir, H., Stoker, L. J., Vuyk, J., Egberts, A. C. G., & Heerdink, E. R. (2013). Prevalence of medication use for somatic disease in institutionalized psychiatric patients. Pharmacopsychiatry, 46(7), 274-280. https://doi.org/10.1055/s-0033-1354405
Sino, C. G. M., Stuffken, R., Heerdink, E. R., Schuurmans, M. J., Souverein, P. C., & Egberts, A. C. G. (2013). The association between prescription change frequency, chronic disease score and hospital admissions: a case control study. BMC pharmacology & toxicology, 14, 39.
Man, W. H., ten Berg, M. J., Wilting, I., Huisman, A., Cahn, W., Douma, J. W., den Breeijen, H., Heerdink, E. R., Egberts, A. C. G., & van Solinge, W. W. (2013). Fluorescence of neutrophil granulocytes as a biomarker for clozapine use. European Neuropsychopharmacology, 23(11), 1408-1413. http://www.ncbi.nlm.nih.gov/pubmed/24074821
Heerdink, E. R. (2013). Antidepressants and postpartum haemorrhage. BMJ (International edition), 347, 8.
Gregoor, J. G., van der Weide, K., van der Weide, J., Megen, H. J. G. M., Egberts, A. C. G., & Heerdink, E. R. (2013). The association between CYP2D6 genotype and switching antipsychotic medication to clozapine. European Journal of Clinical Pharmacology, 69(11), 1927-32.
Vervloet, M., Spreeuwenberg, P., Bouvy, M. L., Heerdink, E. R., de Bakker, D. H., & van Dijk, L. (2013). Lazy Sunday afternoons: the negative impact of interruptions in patients' daily routine on adherence to oral antidiabetic medication. A multilevel analysis of electronic monitoring data. European Journal of Clinical Pharmacology, 69(8), 1599-606.
Scheifes, A., de Jong, D., Stolker, J. J., Nijman, H. L. I., Egberts, A. C. G., & Heerdink, E. R. (2013). Prevalence and characteristics of psychotropic drug use in institutionalized children and adolescents with mild intellectual disability. Research in Developmental Disabilities, 34, 3159-3167.
Hazekamp, A., & Heerdink, E. R. (2013). The prevalence and incidence of medicinal cannabis on prescription in The Netherlands. European Journal of Clinical Pharmacology, 69(8), 1575-80.
Abdullah-Koolmees, H., Gerbranda, T., Deneer, V. H. M., Tjoeng, M. M., De Ridder, A. J., Gardarsdottir, H., & Heerdink, E. R. (2013). Discontinuation of anticoagulant care during admission to a psychiatric hospital. European Journal of Clinical Pharmacology, 69(4), 1025-9. https://doi.org/10.1007/s00228-012-1398-z

Professional publications

Stuffken, R., Souverein, P. C., Egberts, A. C. G., & Heerdink, E. R. (2013). Discontinuïteit in gebruik van psychofarmaca bij ziekenhuisopname. PW Wetenschappelijk Platform, 7(7), a1322.
Tenback, D. E., van Kessel, F., Jessurun, J., Pijl, Y. J., Heerdink, E. R., & van Harten, P. N. (2013). [Risk factors for inactivity in patients in long-term care with severe mental illness]. Tijdschrift voor Psychiatrie, 55(2), 83-91.

Other output

Kooij, M., Van Wijk, B., Heerdink, E. R., De Boer, A., & Bouvy, M. L. (2013). A community pharmacist-led intervention to improve adherence to lipid-lowering treatment by counseling and an electronic reminder device: Results of a randomized controlled trial in The Netherlands. International Journal of Clinical Pharmacy, 35(5), 879-880. https://doi.org/10.1007/s11096-013-9801-0
Kooy, M. J., Heerdink, E. R., Van Geffen, E. C., Geers, H. C., & Bouvy, M. L. (2013). Effects telephone counselling intervention by pharmacist on beliefs about medicines for patients starting treatment: Results of an interim analysis of a cluster randomized controlled trial. International Journal of Clinical Pharmacy, 35(5), 896-897. Article CP-PC29. https://doi.org/10.1007/s11096-013-9801-0

2012

Scholarly publications

Van Dijk, M. H., Bulk, S., Van Oppen, A. C. C., Egberts, A. C. G., Heerdink, E. R., & Lindhout, D. (2012). Spectrum of neural tube defects after prenatal antiepileptic drug exposure: Extensive case series. Archives of Disease in Childhood, 97, 427-428. https://doi.org/10.1136/archdischild-2012-302724.1508
Risselada, A. J., Mulder, H., Heerdink, E. R., Gonera, R. K., & Egberts, T. C. (2012). Association Between HTR2C Polymorphisms and Obesity in Patients Without Antipsychotic Drugs. Journal of Clinical Psychopharmacology, 32(5), 715-740. http://www.ncbi.nlm.nih.gov/pubmed/22926610
de Hoogd, S., Overbeek, W. A., Heerdink, E. R., Correll, C. U., de Graeff, E. R., & Staal, W. G. (2012). Differences in body mass index z-scores and weight status in a Dutch pediatric psychiatric population with and without use of second generation antipsychotics. Journal of Child and Adolescent Psychopharmacology, 22, 166-173.
Kleijer, B. C., Koek, H. L., Van Marum, R. J., Jansen, P. A. F., Egberts, T. C. G., & Heerdink, E. R. (2012). Risk of acute coronary syndrome in elderly users of antipsychotic drugs: A nested case-control study. Heart, 98(15), 1166-1171. https://doi.org/10.1136/heartjnl-2012-301801

Professional publications

Knol, W., Kleijer, B. C., Heerdink, E. R., Schobben, A. F. A. M., Egberts, A. C. G., van Marum, R. J., & Jansen, P. A. F. (2012). Bijwerkingen van antipsychotica. Tijdschrift voor Ouderengeneeskunde, 3, 148-152.

Other output

Thengilsdottir, G., Gardarsdottir, H., Almarsdottir, A. B., McClure, C. B., & Heerdink, E. R. (2012). Does Lifting an Administrative Restriction on Antidepressant Drug Prescribing Influence Treatment Patterns? Pharmacoepidemiology and Drug Safety, 21, 436-437.
Abdullah-Koolmees, H., Gardarsdottir, H., Stoker, L. S., Vuyk, J., Egberts, T. C. G., & Heerdink, E. R. (2012). Prevalence of Medication Use for Somatic Disease in Hospitalized Psychiatric Patients. Pharmacoepidemiology and Drug Safety, 21, 435-436.
Abdullah-Koolmees, H., Gerbranda, T., Deneer, V. H. M., Tjoeng, M. M., De Ridder, A. J. M., Gardarsdottir, H., & Heerdink, E. R. (2012). Discontinuation of Anticoagulant Care during Admission in a Psychiatric Hospital. Pharmacoepidemiology and Drug Safety, 21, 287-287.

2011

Scholarly publications

Derijks, H. J., Heerdink, E. R., De Koning, G. H. P., Janknegt, R., & Egberts, A. C. G. (2011). Invloed van antidepressiva op de glucosehuishouding: Farmacologisch profielvoorspelt risico. Pharmaceutisch Weekblad, 146(22-23), 30-33.
Gregoor, J. G., van der Weide, J., Loovers, H. M., Megen, H. J. G. M., Egberts, A. C. G., & Heerdink, E. R. (2011). Polymorphisms of the LEP, LEPR and HTR2C gene: obesity and BMI change in patients using antipsychotic medication in a naturalistic setting. Pharmacogenomics, 12(6), 919-23.
van Geffen, E. C. G., Hermsen, J. H., Heerdink, E. R., Egberts, A. C. G., Verbeek-Heida, P. M., & van Hulten, R. (2011). The decision to continue or discontinue treatment: Experiences and beliefs of users of selective serotonin-reuptake inhibitors in the initial months-A qualitative study. Research in Social and Administrative Pharmacy, 7(2), 134-50. http://www.ncbi.nlm.nih.gov/pubmed/21272543
Verdel, B. M., Souverein, P. C., Meenks, S. D., Heerdink, E. R., Leufkens, H. G. M., & Egberts, A. C. G. (2011). Use of serotonergic drugs and the risk of bleeding. Clinical Pharmacology and Therapeutics, 89(1), 89-96.
Scheifes, A., Stolker, J. J., Egberts, A. C. G., Nijman, H. L. I., & Heerdink, E. R. (2011). Representation of people with intellectual disabilities in randomised controlled trials on antipsychotic treatment for behavioural problems. Journal of Intellectual Disability Research, 55(7), 650-664.
Geers, H. C. J., Bouvy, M. L., & Heerdink, E. R. (2011). Estimates of statin discontinuation rates are influenced by exposure and outcome definitions. Annals of Pharmacotherapy, 45(5), 576-81.
Risselada, A. J., Mulder, J., Heerdink, E. R., & Egberts, A. C. G. (2011). Pharmacogenetic testing to predict antipsychotic-induced weight gain: a systematic review. Pharmacogenomics, 12(8), 1213-1227.
Geers, H. C. J., Bouvy, M. L., & Heerdink, E. R. (2011). Influence of therapeutic complexity on medication adherence in the Netherlands. Archives of Internal Medicine, 171(9), 864-5; author reply 865. http://www.ncbi.nlm.nih.gov/pubmed/21555670

2010

Scholarly publications

Kleijer, B. C., Heerdink, E. R., & Van Marum, R. J. (2010). Antipsychotics and venous thrombosis: Dutch experience differs. BMJ (Online), 341(7777), 793. Article c5631. https://doi.org/10.1136/bmj.c5631
van den Ban, E., Souverein, P. C., Swaab, H., van Engeland, H., Egberts, T. C. G., & Heerdink, E. R. (2010). Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the netherlands. ADHD Attention Deficit and Hyperactivity Disorders, 2(4), 213-220. https://doi.org/10.1007/s12402-010-0044-9
Gardarsdottir, H., Egberts, T. C. G., & Heerdink, E. R. (2010). The association between patient-reported drug taking and gaps and overlaps in antidepressant drug dispensing. Annals of Pharmacotherapy, 44(11), 1755-1761. https://doi.org/10.1345/aph.1P162
Gardarsdottir, H., Souverein, P. C., Egberts, T. C. G., & Heerdink, E. R. (2010). Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length. Journal of Clinical Epidemiology, 63(4), 422-7. https://doi.org/10.1016/j.jclinepi.2009.07.001
Gardarsdottir, H., Egberts, A. C. G., & Heerdink, E. R. (2010). Transitions from General Practitioner to Psychiatrist Care (or vice versa) during a first antidepressant treatment episode. Pharmacopsychiatry, 43(5), 179-183. https://doi.org/10.1055/s-0030-1249096
van Geffen, E. C. G., Heerdink, E. R., Hugtenburg, J. G., Siero, F. W., Egberts, A. C. G., & van Hulten, R. (2010). Patients' perceptions and illness severity at start of antidepressant treatment in general practice. The International Journal of Pharmacy Practice, 18(4), 217-25.
Gardarsdottir, H., Egberts, T. C. G., van Dijk, L., & Heerdink, E. R. (2010). Seasonal patterns of initiating antidepressant therapy in general practice in the Netherlands during 2002-2007. Journal of Affective Disorders, 122(3), 208-12. https://doi.org/10.1016/j.jad.2009.06.033
Gregoor, J. G., Mulder, H., Cohen, D., Megen, H. J. G. M., Egberts, A. C. G., Heerdink, E. R., & van der Weide, J. (2010). Combined HTR2C-LEP Genotype as a Determinant of Obesity in Patients Using Antipsychotic Medication. Journal of Clinical Psychopharmacology, 30(6), 702-705.
Risselada, A. J., Mulder, H., Heerdink, E. R., Grube, A. M., Wilmink, F. W., & Egberts, A. C. G. (2010). The association between serotonin 2C receptor polymorphisms and weight gain and eating behavior in patients using mirtazapine: a prospective follow-up study. Journal of Clinical Psychopharmacology, 30(2), 207-9.
Laan, W., van der Does, Y., Sezgi, B., Smeets, H. M., Stolker, J. J., de Wit, N. J., & Heerdink, E. R. (2010). Low treatment adherence with antipsychotics is associated with relapse in psychotic disorders within six months after discharge. Pharmacopsychiatry, 43(6), 221-224. http://www.ncbi.nlm.nih.gov/pubmed/20503150
Kleijer, B. C., Heerdink, E. R., Egberts, A. C. G., Jansen, P. A. F., & van Marum, R. J. (2010). Antipsychotic drug use and the risk of venous thromboembolism in elderly patients. Journal of Clinical Psychopharmacology, 30(5), 526-530.
Knol, M. J., Janssen, K. J. M., Donders, A. R. T., Egberts, A. C. G., Heerdink, E. R., Grobbee, D. E., Moons, K. G. M., & Geerlings, M. I. (2010). Unpredictable bias when using the missing indicator method or complete case analysis for missing confounder values: an empirical example. Journal of Clinical Epidemiology, 63(7), 728-36. http://www.ncbi.nlm.nih.gov/pubmed/20346625
van den Ban, E. F., Souverein, P. C., Swaab, H., van Engeland, H., Egberts, A. C. G., & Heerdink, E. R. (2010). Less discontunuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands. ADHD Attention Deficit and Hyperactivity Disorders, 2, 213-220.
Gregoor, J. G., van der Weide, J., Loovers, H. M., Megen, H. J. G. M., Egberts, A. C. G., & Heerdink, E. R. (2010). Association between LEP- and LEPR gene polymorphisms and dyslipidemia in patients using atypical antipsychotic medication. Psychiatric Genetics, 20, 311-316.
Goedhard, L. E., Stolker, J. J., Nijman, H. L. I., Egberts, A. C. G., & Heerdink, E. R. (2010). Trials assessing parmacotherapeutic management of aggression in psychiatric patients: comparability with clinical practice. Pharmacopsychiatry, 43(6), 205-9.
Stolk, P., Souverein, P. C., Wilting, I., Leufkens, H. G. M., Klein, D. F., Rapoport, S. I., & Heerdink, E. R. (2010). Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder. Prostaglandins, Leukotrienes and Essential Fatty Acids, 82(1), 9-14.
Liem, T. B. Y., Heerdink, E. R., Egberts, A. C. G., & Rademaker, C. M. A. (2010). Quantifying antibiotic use in paediatrics: a proposal for neonatal DDDs. European Journal of Clinical Microbiology & Infectious Diseases, 29(10), 1301-3.

Professional publications

Kleijer, B. C., Van Marum, R. J., Egberts, A. C. G. T., Jansen, P. A. F., Frijters, D. H. M., Heerdink, E. R. R., & Ribbe, M. W. (2010). Het beloop van gedragsproblemen bij oudere verpleeghuispatiënten met dementie die worden behandeld met antipsychotica. Tijdschrift voor Ouderengeneeskunde, 2010(2), 70-79.
Kleijer, B. C., van Marum, R. J., Egberts, T. C., Jansen, P. A. F., Frijters, D., & Heerdink, E. R. (2010). Het beloop van gedragsproblemen bij oudere verpleeghuispatienten met dementie die worden behandeld met antipsychotical. International Psychogeriatrics, 21(5), 70-79.
Derijks, H. J., Heerdink, E. R., Janknegt, R., de Koning, G. H. P., Olivier, B., Loonen, A. J. M., & Egberts, T. C. (2010). Farmacologische profielen van antidepressiva. Pharmaceutisch Weekblad, 4(5), 79-85.

Other output

Gregoor, J. G., van der Weide, J., Loovers, H. M., Megens, H. J., Egberts, A. C. G., & Heerdink, E. R. (2010). Association between LEP- and LEPRGene Polymorphisms and Dyslipidemia in Patients Using Atypical Antipsychotic Medication. S278, 657. Abstract from Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK.
Goedhard, L. E., Stolker, J. J., Nijman, H. L., Egberts, A. C. G., & Heerdink, E. R. (2010). The Association of Aggression and Medication Use with Treatment Outcome of Hospitalized Psychiatric Patients. S151, 354. Abstract from Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK.
Gardarsdottir, H., Egberts, A. C. G., & Heerdink, E. R. (2010). Transitions from General Practitioner to Psychiatrist Care (Or Vice Versa) During a First Antidepressant Treatment Episode. S272, 643. Abstract from Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK.
Goedhard, L. E., Stolker, J. J., Nijman, H. L., Egberts, T. C., & Heerdink, E. R. (2010). Trials Assessing Pharmacotherapeutical Management of Aggression in Psychiatric Patients: Comparability with Clinical Practice. S153-S153. Abstract from 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
https://dspace.library.uu.nl/bitstream/handle/1874/203045/GoedhardTrialsAssessingPharmacotherapeuticManagement.pdf?sequence=1
Verdel, B. M., Souverein, P. C., Heerdink, E. R., Leufkens, H. G. M., & Egberts, A. C. G. (2010). Use of Serotonergic Drugs and the Risk of Bleeding. S166, 390. Abstract from Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK.

2009

Scholarly publications

Stolk, P., Heemstra, H. E., Leufkens, H. G., Bloechl-Daum, B., & Heerdink, E. R. (2009). No difference in between-country variability in use of newly approved orphan and non- orphan medicinal products - A pilot study. Orphanet Journal of Rare Diseases, 4(1), Article 27. https://doi.org/10.1186/1750-1172-4-27
Knol, M. J., Heerdink, E. R., Egberts, A. C. G., Grobbee, D. E., & Geerlings, M. I. (2009). Unexpected lower prevalence of depression in patients with diabetes: Selection bias in a waiting room population. Epidemiology, 20(3), 419-423. https://doi.org/10.1097/EDE.0b013e31819d110d
Derijks, H. J., Janknegt, R., Heerdink, E. R., De Koning, F. H. P., Krekels, M. M., Looij, B-J., & Egberts, A. C. G. (2009). Influence of antidepressant use on glycemic control in patients with diabetes mellitus: An open-label comparative study. Journal of Clinical Psychopharmacology, 29(4), 405-408. https://doi.org/10.1097/JCP.0b013e3181acd0ac
Van Geffen, E. C. G., Kruijtbosch, M., Egberts, A. C. G., Heerdink, E. R., & Van Hulten, R. (2009). Patients' perceptions of information received at the start of selective serotonin-reuptake inhibitor treatment: Implications for community pharmacy. Annals of Pharmacotherapy, 43(4), 642-649. https://doi.org/10.1345/aph.1L393
Gardarsdottir, H., Egberts, T. C., Stolker, J. J., & Heerdink, E. R. (2009). Gardarsdottir et al. Respond to "Assessing Treatment Effects With Observational Analyses". American Journal of Epidemiology, 170(3), 288-288. https://doi.org/10.1093/aje/kwp138
van Geffen, E. C. G., Gardarsdottir, H., van Hulten, R., van Dijk, L., Egberts, A. C. G., & Heerdink, E. R. (2009). Initiation of antidepressant therapy: do patients follow the GP's prescription? British Journal of General Practice, 59(559), 81-87. https://doi.org/10.3399/bjgp09X395067
Gardarsdottir, H., van Geffen, E. C. G., Stolker, J. J., Egberts, T. C. G., & Heerdink, E. R. (2009). Does the Length of the First Antidepressant Treatment Episode Influence Risk and Time to a Second Episode? Journal of Clinical Psychopharmacology, 29(1), 69-72. https://doi.org/10.1097/JCP.0b013e31819302b1
Gardarsdottir, H., Egberts, T. C., Stolker, J. J., & Heerdink, E. R. (2009). Duration of Antidepressant Drug Treatment and Its Influence on Risk of Relapse/Recurrence: Immortal and Neglected Time Bias. American Journal of Epidemiology, 170(3), 280-285. https://doi.org/10.1093/aje/kwp142
Wilting, I., Egberts, A. C. G., Heerdink, E. R., Ververs, F. F. T., Meulenbelt, J., & Nolen, W. A. (2009). Evaluation of available treatment guidelines for the management of lithium intoxication. Therapeutic Drug Monitoring, 31(2), 247-260.
Kleijer, B. C., van Marum, R. J., Egberts, A. C. G., Jansen, P. A. F., Knol, W., & Heerdink, E. R. (2009). Risk of cerebrovascular events in elderly users of antipsychotics. Journal of Psychopharmacology, 23(8), 909-914.
Kleijer, B. C., van Marum, R. J., Egberts, A. C. G., Jansen, P. A. F., Frijters, D., Heerdink, E. R., & Ribbe, M. (2009). The course of behavioral problems in elderly nursing home patients with dementia when treated with antipsychotics. International Psychogeriatrics, 21(5), 931-940.
Knol, M. J., Geerlings, M. I., Grobbee, D. E., Egberts, A. C. G., & Heerdink, E. R. (2009). Antidepressant use before and after initiation of diabetes mellitus treatment. Diabetologia, 52(3), 425-432. http://www.springerlink.com/content/u324jr7323l70536/fulltext.pdf
Ravera, S., Hummel, S. A., Stolk, P., Heerdink, E. R., de Gier, J. J., & de Jong-van den Berg, L. T. W. (2009). The use of driving impairing medicines: a European survey. European Journal of Clinical Pharmacology, 65(II), 1139-1147.
Wilting, I., Heerdink, E. R., Mersch, P. P. A., den Boer, J. A., Egberts, A. C. G., & Nolen, W. A. (2009). Association between lithium serum level, mood state, and patient-reported adverse drug reactions during long-term lithium treatment: a naturalistic follow-up study. Bipolar Disorders, 11, 434-440.
Gardarsdottir, H., Egberts, A. C. G., van Dijk, L., Sturkenboom, M. C. J. M., & Heerdink, E. R. (2009). An algorithm to identify antidepressant users with a diagnosis of depression from prescription data. Pharmacoepidemiology and Drug Safety, 18(1), 7-15. https://doi.org/10.1002/pds.1677
Gregoor, J. G., van der Weide, J., Mulder, H., Cohen, D., van Megen, H. J. G. M., Egberts, A. C. G., & Heerdink, E. R. (2009). Polymorphisms of the LEP- and LEPR Gene and Obesity in Patients Using Antipsychotic Medication. Journal of Clinical Psychopharmacology, 29(1), 21-25.
Derijks, H. J., Janknegt, R., Heerdink, E. R., De Koning, F. H. P., Krekels, M. M., Looij, B. J., & Egberts, A. C. G. (2009). Influence of Antidepressant Use on Glycemic Control in Patients With Diabetes Mellitus; an open label comparative study. Journal of Clinical Psychopharmacology, 29(4), 405-408.
Knol, M. J., Heerdink, E. R., Egberts, A. C. G., Grobbee, D. E., & Geerlings, M. I. (2009). Unexpected lower prevalence of depression in patients with diabetes. Epidemiology, 20(3), 419-423. http://www.ncbi.nlm.nih.gov/pubmed/19289958?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=11
van Geffen, E. C. G., Kruijtbosch, M., Egberts, A. C. G., Heerdink, E. R., & van Hulten, R. (2009). Patients perceptions of information received at the start of selective serotonin reuptake inhibitors: implications for community pharmacy. Annals of Pharmacotherapy, 43(5), 642-649.

Professional publications

Derijks, H. J., Meyboom, R. H. B., Heerdink, E. R., de Koning, G. H. P., Janknegt, R., Lindquist, M., & Egberts, A. C. G. (2009). Associatie tussen antidepressivagebruik en glucosedisregulatie: bewijs op basis van bijwerkingenmelding. Pharmaceutisch Weekblad, 3(2), 22-27.
Heerdink, E. R., & Bogers, J. P. A. M. (2009). Antipsychotica tijdens zwangerschap en postpartum. Psyfar, 1, 29-34.
Butterhoff-Terlingen, M. H., Stuffken, R., Egberts, A. C. G., Heerdink, E. R., van Marum, R. J., & Kalisvaart, K. J. (2009). Vergelijking van meetmethoden voor anticholinerge belasting door geneesmiddelen en de relatie met delier bij ouderen die een heupoperatie ondergaan. Pharmaceutisch Weekblad, 3(10), 178-182.
Wilting, I., & Heerdink, E. R. (2009). Oorzaken en gevolgen van polyurie als bijwerking van lithiumgebruik. Psyfar, 1(2009), 19-22.

Other output

Bergman, U., Carvajal, A., Conforti, A., Heerdink, E. R., Lapeyre-Mestre, M., Macias, D., & Vander Stichele, R. H. (2009). Evaluation of Drug Diversion from Community Pharmacies Network: Results 2005-2007 of the OSIAP Europe Survey. Pharmacoepidemiology and Drug Safety, 18, S42.
Sino, C. G. M., Stuffken, R., Heerdink, E. R., Souverein, P. C., Schuurmans, M. J., & Egberts, A. C. G. (2009). Prescription Changes and Chronic Disease Score as Predictors for Hospitalization. Pharmacoepidemiology and Drug Safety, 18, S102.
Gardarsdottir, H., Heerdink, E. R., & Egberts, A. C. G. (2009). Constructing Drug Treatment Episodes from Individual Dispensed Prescriptions: The Influence of the Gap-Length. Pharmacoepidemiology and Drug Safety, 18, S63.

2008

Scholarly publications

Willard, N., Heerdink, R., & Stolker, J. J. (2008). Gebruik is lastig te ontmoedigen: Cannabis nadelig bij antipsychotica. Pharmaceutisch Weekblad, 143(1), 30-31.
Stolk, P., Schneeweiss, S., Leufkens, H. G. M., & Heerdink, E. R. (2008). Impact analysis of the discontinuation of reimbursement: the case of oral contraceptives. Contraception, 78(5), 399-404. https://doi.org/10.1016/j.contraception.2008.06.009
Heerdink, E. R. (2008). Use of antidepressants in pregnancy does not increase risk of postpartum haemorrhage: Commentary. Evidence-Based Mental Health, 11(4), 125. https://doi.org/10.1136/ebmh.11.4.125
Knol, M. J., Derijks, H. J., Geerlings, M. I., Heerdink, E. R., Souverein, P. C., Gorter, K. J., Grobbee, D. E., & Egberts, A. C. G. (2008). Influence of antidepressants on glycaemic control in patients with diabetes mellitus. Pharmacoepidemiology and Drug Safety, 17(6), 577-586.
Tlusta, E., Handoko, K. B., Majoie, M., Egberts, A. C. G., Vlcek, J., & Heerdink, E. R. (2008). Clinical relevance of patients with epilepsy included in clinical trials. Epilepsia, 49(8), 1479-1480.
Gregoor, J. G., van der Weide, J., Mulder, J., van Megen, H. J. G. M., Egberts, A. C. G., & Heerdink, E. R. (2008). Polymorphisms of the LEP- and LEPR Gene and Obesity in Psychiatric Patients Using Antipsychotic Medication. In Pharmacoepidemiology and Drug Safety (pp. S203)
Derijks, H. J., Meyboom, R. H. B., Heerdink, E. R., de Koning, G. H. P., Janknegt, R., Lindquist, M., & Egberts, A. C. G. (2008). The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports. European Journal of Clinical Pharmacology, 64, 531-538.
Wilting, I., Egberts, A. C. G., Movig, K. L. L., van Laarhoven, J. H. M., Heerdink, E. R., & Nolen, W. A. (2008). The Association between Concomitant Use of Serotonergic Antidepressants and Lithium-Induced Polyuria. A Multicenter Medical Chart Review Study. Pharmacopsychiatry, 41, 129-133.
Wilting, I., Souverein, P. C., Nolen, W. A., Egberts, A. C. G., & Heerdink, E. R. (2008). Changes in outpatient lithium treatment in the Netherlands during 1996-2005. Journal of Affective Disorders, 111, 94-99.
Bozkurt, O., Verschuren, W. M. M., van Wieren-de Wijer, B. M. A., Knol, M. J., de Boer, A., Grobbee, D. E., Geerlings, M. I., Heerdink, E. R., & Klungel, O. H. (2008). Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives. Journal of Human Hypertension, 22(11), 774-780. https://doi.org/10.1038/jhh.2008.62
van Dulmen, S., Sluijs, E., van Dijk, L., De Ridder, D. T. D., Heerdink, E. R., & Bensing, J. (2008). Furthering patient adherence: a position paper of the international expert forum on patient adherence based on an internet forum discussion. BMC Health Services Research, 8, 47.
Stuffken, R., Heerdink, E. R., De Koning, F. H. P., Souverein, P. C., & Egberts, A. C. G. (2008). Association Between Hospitalization and Discontinuity of Medication Therapy Used in the Community Setting in the Netherlands. Annals of Pharmacotherapy, 42, 933-939.
Derijks, H. J., Heerdink, E. R., de Koning, F. H., Janknegt, R., Klungel, O. H., & Egberts, A. C. G. (2008). The association between antidepressant use and hypoglycaemia in diabetic patients: a nested case-control study. Pharmacoepidemiology and Drug Safety, 2008(17), 336-344.
Derijks, H. J., Heerdink, E. R., Janknegt, R., De Koning, F. H. P., Olivier, B., Loonen, A. J. M., & Egberts, A. C. G. (2008). Visualizing pharmacological activities of antidepressants: A novel approach. The Open Pharmacology Journal, 2, 54-62. https://doi.org/10.2174/1874143600802010054
Layton, D., Souverein, P. C., Heerdink, E. R., Shakir, S. A., & Egberts, A. C. G. (2008). Prescriber adoption of newly approved selective COX-2 inhibitors. Pharmacoepidemiology and Drug Safety, 2008(17), 1168-1174.
van Geffen, E. C. G., van Hulten, R., Bouvy, M. L., Egberts, A. C. G., & Heerdink, E. R. (2008). Characteristics and Reasons Associated with Nonacceptance of Selective Serotonin-Reuptake Inhibitor Treatment. Annals of Pharmacotherapy, 42, 218-225.
Stolk, P., Belitser, S., Leufkens, H. G. M., & Heerdink, E. R. (2008). Variable Access to Clopidogrel in a Harmonized EU Market. Value in Health, 11(5), 989-995.

Professional publications

Van Geffen, E. C. G., Brugman, M., Van Hulten, R., Bouvy, M. L., Egberts, A. C. G., & Heerdink, E. R. (2008). Vragen en problemen bij stoppen met antidepressiva. Pharmaceutisch Weekblad, 2(5), 106-108.
Stolker, J. J., Scheifes, A., Egberts, A. C. G., & Heerdink, E. R. (2008). Antipsychotica ten onrechte voorgeschreven aan mensen met een verstandelijke beperking en probleemgedrag met agressie. Nederlands Tijdschrift voor Geneeskunde, 152(27), 1501-1502.
Wilting, I., Heerdink, E. R., Nolen, W. A., & Egberts, A. C. G. (2008). Lithium: farmacologie in de psychiatrie. Neuropraxis, 5, 147-153.
Wilting, I., Heerdink, E. R., Nolen, W. A., & Egberts, A. C. G. (2008). Samenhang tussen serumspiegels, bijwerkingen en stemming. Lithium, een waardevol zorgenkind. Pharmaceutisch Weekblad, 51, 24-27.
Wilting, I., Heerdink, E. R., Nolen, W. A., & Egberts, A. C. G. (2008). Lithium, een waardevol zorgenkind. Samenhang tussen serumspiegels, bijwerkingen en stemming. Pharmaceutisch Weekblad, 2008(19 december), 24-26.

Other output

Gardarsdottir, H., Egberts, T. C. G., & Heerdink, E. R. (2008). Neglected and immortal time bias in observational studies: Antidepressant drug use and risk of relapse/recurrence. Pharmacoepidemiology and Drug Safety, 17, S135-S136.
Gardarsdottir, H., Egberts, T. C. G., van Dijk, L., Sturkenboom, M., & Heerdink, E. R. (2008). An algorithm to identify antidepressant users with a diagnosis of depression from prescription data. Pharmacoepidemiology and Drug Safety, 17, S1-S1.
Layton, D., Souverein, P. C., Heerdink, E. R., Egberts, A. C. G., & Shakir, S. A. W. (2008). Evaluating Prescriber Characteristics Associated with NSAID Prescribing Practices in the Netherlands. S66. Abstract from 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Knol, M. J., Heerdink, E. R., Egberts, A. C. G., Grobbee, D. E., & Geerlings, M. I. (2008). Unexpected Lower Prevalence of Depression in Patients with Diabetes: Potential for Selection Bias in Waiting Room Population. S253. Abstract from 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Gardarsdottir, H., Egberts, A. C. G., van Dijk, C. E. M. J., Sturkenboom, M. C. J. M., & Heerdink, E. R. (2008). An Algorithm To Identify Antidepressant Users with a Diagnosis of Depression from Prescription Data. S1. Abstract from 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Stolk, P., Souverein, P. C., Wilting, I., Leufkens, H. G. M., Klein, D. F., Rapoport, S. I., & Heerdink, E. R. (2008). Taking Low Dose Aspirin Is Associated with More Stable Drug Treatment for Lithium Users. S22. Abstract from 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Tlusta, E., Handoko, K. B., Majoie, M., Egberts, A. C. G., Vlcek, J., & Heerdink, E. R. (2008). Highly Selected Subset of Clinical Patients with Epilepsy Qualifies for Antiepileptic Drug Trials. S30. Abstract from 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.

2007

Scholarly publications

Florentinus, S. R., Van Hulten, R., Kloth, M. E. M., Heerdink, E. R., Griens, A. M. G. F., Leufkens, H. G. M., & Groenewegen, P. P. (2007). The effect of pharmacotherapy audit meetings on early new drug prescribing by general practitioners. Annals of Pharmacotherapy, 41(2), 319-324. https://doi.org/10.1345/aph.1H250
Volkers, A. C., Heerdink, E. R., & van Dijk, L. (2007). Antidepressant use and off-label prescribing in children and adolescent in Dutch general practice (2001-2005). Pharmacoepidemiology and Drug Safety, 16(9), 1054-1062. https://doi.org/10.1002/pds.1430
Van Wijk, B. L. G., Avorn, J., Solomon, D. H., Klungel, O. H., Heerdink, E. R., de Boer, A., & Brookhart, A. M. (2007). Herstarten van antihypertensiva. Pharmaceutisch Weekblad, 142(38), 118-120.
van Wijk, B. L. G., Avorn, J., Solomon, D. H., Klungel, O. H., Heerdink, E. R., de Boer, A., & Brookhart, A. M. (2007). Rates and determinants of reinitiating antihypertensive therapy after prolonged stoppage: a population-based study. Journal of Hypertension, 25(3), 689-697. https://doi.org/10.1097/HJH.0b013e3280148a58
Bozkurt, O., de Boer, A., Grobbee, D. E., Heerdink, E. R., Burger, H., & Klungel, O. H. (2007). Pharmacogenetics of glucose-lowering drug treatment: a systematic review. Molecular Diagnosis & Therapy, 11(5), 291-302.
Wilting, I., Fase, S., Martens, E. P., Heerdink, E. R., Nolen, W. A., & Egberts, A. C. G. (2007). The impact of environmental temperature on lithium serum levels. Bipolar Disorders, 2007(9), 603-608.
https://dspace.library.uu.nl/bitstream/handle/1874/27401/wilting_07_theimpactofenvironmentaltemperature.pdf?sequence=2
van Geffen, E. C. G., van der Wal, S. W., van Hulten, R., de Groot, M. C., Egberts, A. C. G., & Heerdink, E. R. (2007). Evaluation of patients' experiences with antidepressants reported by means of a medicine reporting system. European Journal of Clinical Pharmacology, 2007(63), 1193-1199.
https://dspace.library.uu.nl/bitstream/handle/1874/27399/geffen_07_evaluationofpatientsexperiences.pdf?sequence=1
van Dijk, L., Heerdink, E. R., Somai, D., van Dulmen, S., Sluijs, E. M., De Ridder, D. T. D., Griens, A. M., & Bensing, J. (2007). Patient risk profiles and practice variation in nonadherence to antidepressants, antihypertensives and oral hypoglycemics. BMC Health Services Research, 7, 51-51.
Goedhard, L. E., Stolker, J. J., Nijman, H. L. I., Egberts, A. C. G., & Heerdink, E. R. (2007). Association between aggression and medication changes. In P. Callaghan, T. Palmstierna, H. Nijman, & N. Oud (Eds.), Violence in Clinical Psychiatry: proceedings of the 5th European congress (pp. 82-83). Kananah.
Stolk, P., Souverein, P. C., Leufkens, H. G. M., Weil, J. G., Egberts, A. C. G., & Heerdink, E. R. (2007). The Association between Exposure to COX-2 Inhibitors and Schizophrenia Deterioration. Pharmacopsychiatry, 40, 111-115.
https://dspace.library.uu.nl/bitstream/handle/1874/27376/stolk_07_theassociationbetweenexposure.pdf?sequence=2
Knol, M. J., Heerdink, E. R., Egberts, A. C. G., Geerlings, M. I., Gorter, K. J., Numans, M. E., Grobbee, D. E., Klungel, O. H., & Burger, H. (2007). Depressive symptoms in subjects with diagnosed and undiagnosed Type 2 diabetes. Psychosomatic Medicine, 69(4), 300-305.
https://dspace.library.uu.nl/bitstream/handle/1874/27104/knol_07_depressivesymptomsinsubjects.pdf?sequence=1
Stolker, J. J., Goedhard, L. E., Egberts, A. C. G., & Heerdink, E. R. (2007). Treatment of aggression with psychotropic drugs: bridge between evidence based practice and practice based evidence. In P. Callaghan, T. Palmstierna, H. Nijman, & N. Oud (Eds.), Violence in Clinical Psychiatry: proceedings of the 5th European congreass (pp. 308-313). Kavanah.
Wilting, I., Baumgarten, R., Movig, K. L. L., van Laarhoven, J., Apperloo, A. J., Nolen, W. A., Heerdink, E. R., Knoers, V. A. M., & Egberts, A. C. G. (2007). Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration. European Journal of Pharmacology, 566(2007), 50-57.
https://dspace.library.uu.nl/bitstream/handle/1874/27380/wilting_07_urineosmolalitycyclic_amp_andaquaporin2inurine.pdf?sequence=2
Goedhard, L. E., Stolker, J. J., Nijman, H. L. I., Egberts, A. C. G., & Heerdink, E. R. (2007). Aggression of Psychiatric Patients Associated with the Use of As-needed Medication. Pharmacopsychiatry, 2007(40), 25-29.
https://dspace.library.uu.nl/bitstream/handle/1874/27093/goedhard_07_aggressionofpsychiatricpatients.pdf?sequence=1
Wilting, I., de Vries, F., Thio, B. M. K. S., Cooper, C., Heerdink, E. R., Leufkens, H. G. M., Nolen, W. A., Egberts, A. C. G., & van Staa, T. P. (2007). Lithium use and the risk of fractures. Bone, 40(5), 1252-1258. https://doi.org/10.1016/j.bone.2006.12.055
de Bakker, D. H., Coffie, D. S. V., Heerdink, E. R., van Dijk, L., & Groenewegen, P. P. (2007). Determinants of the range of drugs prescribed in general practice: a cross-sectional analysis. BMC Health Services Research, 7, 132. Article 132.
https://dspace.library.uu.nl/bitstream/handle/1874/27403/heerdink_07_determinantsofrangeofdrugsprecribed.pdf?sequence=1
Bozkurt, O., de Boer, A., Grobbee, D. E., Heerdink, E. R., Burger, H., & Klungel, O. H. (2007). Pharmacogenetics of glucose-lowering drug treatment: a systematic review. Molecular Diagnosis & Therapy, 11(8), 291-302.
https://dspace.library.uu.nl/bitstream/handle/1874/27324/bozkurt_07_pharmacogeneticsofglucoselowering.pdf?sequence=1
Mulder, J., Heerdink, E. R., van Iersel, E. E., Wilmink, F. W., & Egberts, A. C. G. (2007). Prevalence of Patients Using Drugs Metabolized by Cytochrome P450 2D6 in Different Populations: a Cross Sectional Study. Annals of Pharmacotherapy, 41, 408-413.
https://dspace.library.uu.nl/bitstream/handle/1874/27371/mulder_07_prevalenceofpatientsusingdrugs.pdf?sequence=2
Knol, M. J., Geerlings, M. I., Egberts, A. C. G., Gorter, K. J., Grobbee, D. E., & Heerdink, E. R. (2007). No increased incidence of diabetes in antidepressant users. International Clinical Psychopharmacology, 22(6), 382-386.
https://dspace.library.uu.nl/bitstream/handle/1874/27465/knol_07_noincreasedincidenceofdiabetes.pdf?sequence=1
Dulmen, S., Sluijs, E., van Dijk, L., De Ridder, D. T. D., Heerdink, E. R., & Bensing, J. (2007). Patient adherence to medical treatment: a review of reviews. BMC Health Services Research, 7, 55-55.
https://dspace.library.uu.nl/bitstream/handle/1874/27202/heerdink_07_patientadherencetomedicaltreatment.pdf?sequence=1
Florentinus, S. R., Van Hulten, R. P., Kloth, S., Heerdink, E. R., Griens, F. A. M. G., Leufkens, H. G. M., & Groenwegen, P. (2007). The Effect of Pharmacotherapy Audit Meetings on Early New Drug Prescibing by General Practitioners. Annals of Pharmacotherapy, 41.
https://dspace.library.uu.nl/bitstream/handle/1874/27356/florentinus_07_theeffectofpharmacotherapyauditmeetings.pdf?sequence=1
Gardarsdottir, H., Heerdink, E. R., van Dijk, L., & Egberts, A. C. G. (2007). Indications for antidepressant drug prescribing in general practice in the Netherlands. Journal of Affective Disorders, 98(1-2), 109-115. https://doi.org/10.1016/j.jad.2006.07.003

Professional publications

van der Hulst, R., Stolker, J. J., Hugenholtz, G. W. K., & Heerdink, E. R. (2007). Channeling na introductie van het nieuwe antipsychoticum aripiprazol. In Tijdschrift voor Psyciatrie (pp. S215)
Stolker, J. J., Scheifes, A., & Heerdink, E. R. (2007). Kwaliteit van de behandeling met psychofarmaca van mensen met een verstandelijke beperking. In R. Didden, & X. Moonen (Eds.), Met het oog op behandeling: effectieve behandeling van gedragsstoornissen van mensen met een licht verstandelijke beperking (pp. 35-39). Landelijk Kenniscentrum LVG / Expertise Centrum de Borg.

Other output

van Wijk, B. L. G., Avorn, J., Solomon, D. H., Klungel, O. H., Heerdink, E. R., de Boer, A., & Brookhart, A. M. (2007). Rates and Determinants of Reinitiating Antihypertensive Therapy after Prolonged Stoppage. S199. Abstract from 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Kleijer, B. C., van Marum, R. J., Knol, W., Egberts, A. C. G., & Heerdink, E. R. (2007). The Temporal Relationship between Antipsychotic Use and Stroke among Community-Dwelling Elderly: Further Support for a Causal Relationship. S074. Abstract from Unknown event, Asilomar, USA.
van der Hulst, R., Stolker, J. J., Hugenholtz, G. W. K., Egberts, A. C. G., & Heerdink, E. R. (2007). Channelling of Aripiprazole to More Complex Psychiatric Patients. S157. Abstract from 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
van Geffen, E. C. G., Van Hulten, R. P., Bouvy, M. L., Egberts, A. C. G., & Heerdink, E. R. (2007). Characteristics Associated with Non-Acceptance of Antidepressant Treatment. S221. Abstract from 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Knol, M. J., Derijks, H. J., Geerlings, M. I., Heerdink, E. R., Souverein, P. C., Grobbee, D. E., & Egberts, A. C. G. (2007). Influence of Antidepressant Use on Insuline Need in Diabetes Mellitus Patients. S127. Abstract from Unknown event, Asilomar, USA.
Stuffken, R., Heerdink, E. R., Souverein, P. C., & Egberts, A. C. G. (2007). Hospitalisation as a Determinant for Discontinuity of Drug Use. P.014. Abstract from ISoP.
Goedhard, L. E., Stolker, J. J., Nijman, H. L. I., Egberts, A. C. G., & Heerdink, E. R. (2007). Association between Aggression and Medication Changes. S127. Abstract from 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Layton, D., Souverein, P. C., Heerdink, E. R., Egberts, A. C. G., & Shakir, S. A. W. (2007). Nonsteroidal Anti-Inflammatory Drug (NSAID) Utilisation Factors in the Netherlands. P.029. Abstract from ISoP.
Goedhard, L. E., Heerdink, E. R., Stolker, J. J., Nijman, H. L. I., & Egberts, A. C. G. (2007). Leidt agressie tot veranderingen in de reguliere medicatie. S113. Abstract from Unknown event, Asilomar, USA.

2006

Scholarly publications

Heerdink, E. R., Stolker, J. J., & Egberts, A. C. G. (2006). Reactie op 'Imago'. Tijdschrift voor Psychiatrie, 48(2), 165-166.
Florentinus, S. R., Van Hulten, R., Kramer, M., Van Dijk, L., Heerdink, E. R., Leufkens, H. G. M., & Groenewegen, P. P. (2006). Which pharmacists contribute to high-level pharmacotherapy audit meetings with general practitioners? Annals of Pharmacotherapy, 40(9), 1640-1646. https://doi.org/10.1345/aph.1H180
Wilting, I., De Vries, F., Thio, B. M. K. S., Cooper, C., Heerdink, E. R., Leufkens, H. G. M., Nolen, W. A., Egberts, A. C. G., & van Staa, T. P. (2006). The risk of fractures in patients currenly or previously using lithium. British Journal of Clinical Pharmacology.
Van Wijk, B. L. G., Klungel, O. H., Heerdink, E. R., & de Boer, A. (2006). Generic substitution of antihypertensive drugs: does it affect adherence? Annals of Pharmacotherapy, 40(1), 15-20. https://doi.org/10.1345/aph.1G163
Van Wijk, B. L. G., Klungel, O. H., Heerdink, E. R., & de Boer, A. (2006). A comparison of two multiple-characteristic decision-making models for the comparison of antihypertensive drug classes: Simple Additive Weighting (SAW) and Technique for Order Preference by Similarity to an Ideal Solution (TOPSIS). American journal of cardiovascular drugs : drugs, devices, and other interventions, 6(4), 251-258.
Gardarsdottir, H., Heerdink, ER., & Egberts, ACG. (2006). Potential bias in pharmacoepidemiological studies due to the length of the drug free period: a study on antidepressant drug use in adults in the Netherlands. Pharmacoepidemiology and Drug Safety, 15(5), 338-343. https://doi.org/10.1002/pds.1223
Hugenholtz, G. W. K., Heerdink, E. R., Stolker, J. J., Meijer, W. E. E., Egberts, A. C. G., & Nolen, W. A. (2006). Haloperidol Dose When Used as Active Comparator in Randomized Controlled Trials With Atypical Antipsychotics in Schizophrenia: Comparison With Officially Recommended Doses. Journal of Clinical Psychiatry, 67(6), 897-903.
Florentinus, S. R., Van Hulten, R. P., Kramer, M., van Dijk, L., Heerdink, E. R., Leufkens, H. G. M., & Groenewegen, P. P. (2006). Which Pharmacists Contribute to High-Level Pharmacotherapy Audit Meeting with General Practioners? Annals of Pharmacotherapy, 40.
https://dspace.library.uu.nl/bitstream/handle/1874/27340/florentinus_06_whichpharmacistscontribute.pdf?sequence=1
Goedhard, L. E., Stolker, J. J., Heerdink, E. R., Olivier, B., & Egberts, A. C. G. (2006). The pharmacological management of aggression. In D. Richter, & R. Whittington (Eds.), Violence in Mental Health Settings (pp. 173-192). Springer.
Van Wijk, B. L. G., Klungel, O. H., Heerdink, E. R., & de Boer, A. (2006). Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy. Pharmacoepidemiology and Drug Safety, 15(8), 587-93. https://doi.org/10.1002/pds.1239
Hugtenburg, J. G., Witte, I., & Heerdink, E. R. (2006). Determinants of compliance with methylphenidate therapy in children. Acta Paediatrica, 95, 1674-1676.
https://dspace.library.uu.nl/bitstream/handle/1874/27350/heerdink_06_determinantscompliancemethylphenidate.pdf?sequence=1
Florentinus, S. R., Souverein, P. C., Griens, F. A. M. G., Groenewegen, P. P., Leufkens, B. G. M., & Heerdink, E. R. (2006). Linking community pharmacy dispensing data to prescribing data of general practitioners. BMC medical informatics and decision making [E], 6, Article 18. https://doi.org/10.1186/1472-6947-6-18
Geers, H. C. J., de Blaey, C. J., Egberts, A. C. G., Bouvy, M. L., & Heerdink, E. R. (2006). Early Identification of Long-Term Poor Adherence in Ambulatory Patients. Annals of Pharmacotherapy, 40, 2277-2278.
https://dspace.library.uu.nl/bitstream/handle/1874/27354/geers_06_earlyidentificationlongtermpooradherence2006.pdf?sequence=1
Gardarsdottir, H., Heerdink, E. R., & Egberts, A. C. G. (2006). Potential bias in pharmacoepidemiological studies due to the length of the drug free period: a study on antidepressant drug use in adults in the Netherlands. Pharmacoepidemiology and Drug Safety, 15, 338-343.
https://dspace.library.uu.nl/bitstream/handle/1874/19727/egberts_06_Potential_bias.pdf?sequence=1
Goedhard, L. E., Stolker, J. J., Heerdink, E. R., Nijman, H. L. I., Olivier, B., & Egberts, A. C. G. (2006). Pharmacotherapy for the treatment of aggressive behavior in general adult psychiatry: A systematic review. Journal of Clinical Psychiatry, 67(7), 1013-1023.
Van Wijk, B. L. G., Klungel, O. H., Heerdink, E. R., & de Boer, A. (2006). Refill persistence with chronic medication assessed from a pharmacy database was influenced by method of calculation. Journal of Clinical Epidemiology, 59(1), 11-17. https://doi.org/10.1016/j.jclinepi.2005.05.005
Stolk, P., van Wijk, B. L. G., Leufkens, H. G. M., & Heerdink, E. R. (2006). Between-country variation in the utilization of antihypertensive agents: guidelines and clinical practice. Journal of Human Hypertension, 1-6.
https://dspace.library.uu.nl/bitstream/handle/1874/27443/stolk_06_betweencountryvariation.pdf?sequence=2

Professional publications

Heerdink, E. R. (2006). Geneesmiddeleninteracties in de praktijk. In Het medisch jaar 2006 (pp. 72-78). Bohn Stafleu van Loghum.
https://dspace.library.uu.nl/bitstream/handle/1874/27347/heerdink_geneelmiddeleninteractiesindepraktijk.pdf?sequence=1
Wilting, I., Baumgarten, R., Movig, K. L. L., Laarhoven, J., Apperloo, A. J., Nolen, W. A., Heerdink, E. R., Knoers, N. V., & Egberts, A. C. G. (2006). Focus op het onderliggend mechanisme. Lithium-geïnduceerde nefrogene diabetes insipidus. Pharmaceutisch Weekblad, 11, 389-393.
https://dspace.library.uu.nl/bitstream/handle/1874/27330/wilting_06_focusophetonderliggend.pdf?sequence=2

Other output

Gardarsdottir, H., Heerdink, E. R., van Dijk, L., & Egberts, A. C. G. (2006). Indications for antidepressant drug prescribing in general practice in the Netherlands. Pharmacoepidemiology and Drug Safety, 15, S163-S164.
Wilting, I., de Vries, F., Thio, B. M. K. S., Cooper, C., Heerdink, E. R., Leufkens, H. G. M., Nolen, W. A., Egberts, A. C. G., & van Staa, T. P. (2006). The Risk of Fractures in Patients Currently or Previously Using Lithium. S41. Abstract from Unknown event, Asilomar, USA.
Lapeyre-Mestre, M., Gony, M., Bergman, U., Carvajal, A., Conforti, A., Heerdink, E. R., Macias, D., & Vander Stichele, R. (2006). The OSIAP Europe Project: Presentation of a European Pharmacoepidemiological Survey of the Misuse or Abuse of Marketed Drugs. S74. Abstract from Unknown event, Asilomar, USA.
Bozkurt, O., Verschuren, M. W. M., de Boer, A., Grobbee, D. E., Geerlings, M. I., Heerdink, E. R., Stricker, B. H. C., & Klungel, O. H. (2006). Interaction between Genetic Polymorphisms in the Renin-Angiotensin-System and the Risk of Diabetes Associated with the Use of ACE Inhibitors. S135. Abstract from Unknown event, Asilomar, USA.
Knol, M. J., Heerdink, E. R., Egberts, A. C. G., Gorter, K. J., Numans, M. E., Grobbee, D. E., Klungel, O. H., & Burger, H. (2006). Depression in type 2 diabetes consequence rather than cause. European Journal of Epidemiology, 21(suppl.), 85.
Gardarsdottir, H., Heerdink, E. R., van Dijk, L., & Egberts, A. C. G. (2006). Indications for Antidepressant Drug Prescribing in General Practice in the Netherlands. S163. Abstract from Unknown event, Asilomar, USA.
van Wijk, B. L. G., Klungel, O. H., Heerdink, E. R., & de Boer, A. (2006). A Comparison of Two Multiple Characteristics Decision Making Techniques for the Comparison of Antihypertensive Drugs: Simple additive Weighting and Technique for Order Preference by Similarity to an Ideal Solution. S224. Abstract from Unknown event, Asilomar, USA.
Stolk, P., Souverein, P. C., Tatt, I. D., Egberts, A. C. G., Leufkens, H. G. M., Weil, J. G., & Heerdink, E. R. (2006). Do COX-2 Inhibitors Prevent Deterioration of Schizophrenia? A Nested Case-Control Study. S262. Abstract from Unknown event, Asilomar, USA.
Stolk, P., Schneeweiss, S., Vander Stichele, R. H., & Heerdink, E. R. (2006). Methodologies and Platforms for Policy Evaluation of Pharmaceutical Interventions. S20. Abstract from Unknown event, Asilomar, USA.
van Dijk, L., Somai, D., Heerdink, E. R., van Dulmen, S., Sluijs, E., De Ridder, D. T. D., & Bensing, J. (2006). Adherence to chronic medication in Dutch Primary Care. S200. Abstract from Unknown event, Asilomar, USA.
Stuffken, R., Heerdink, E. R., de Koning, G. H. P., Souverein, P. C., & Egberts, A. C. G. (2006). Is Hospitalisation a Determinant for Discontinuity of Drug Use?. S101. Abstract from Unknown event, Asilomar, USA.
Bozkurt, O., Verschuren, W. M. M., de Boer, A., Grobbee, D. E., Geerlings, M. I., Heerdink, E. R., Stricker, B. H. C., & Klungel, O. H. (2006). Genetic polymorphisms in the ras and risk of diabetes associated with the use of ACE inhibitors: the Doetinchem study. 119. Abstract from Unknown event, Asilomar, USA.
van Geffen, E. C. G., Van Hulten, R. P., Bouvy, M. L., Heerdink, E. R., & Egberts, A. C. G. (2006). Patient Reports on Discontinuation of Antidepressants. S239. Abstract from Unknown event, Asilomar, USA.
Derijks, H. J., de Koning, G. H. P., Heerdink, E. R., Janknegt, R., Klungel, O. H., & Egberts, A. C. G. (2006). The Association between Antidepressant Use and Hypoglycemia in Diabetic Patients: A Nested Case-Control Study. S42. Abstract from Unknown event, Asilomar, USA.
Geers, H. C. J., de Blaey, C. J., Egberts, A. C. G., & Heerdink, E. R. (2006). Early Identification of Long Term Poor Compliance in Ambulatory Patients Using a Multivariate Risk Score Model. S160. Abstract from Unknown event, Asilomar, USA.

2005

Scholarly publications

Florentinus, S. R., Heerdink, E. R., de Boer, A., van Dijk, L., & Leufkens, H. G. M. (2005). Erratum: The trade-off between cardiovascular and gastrointestinal effects of rofecoxib (Pharmacoepidemiology and Drug Safety (2005) (14)). Pharmacoepidemiology and Drug Safety, 14(9). https://doi.org/10.1002/pds.1139
Derijks, H. J., De Koning, F. H. P., Meyboom, R. H., Heerdink, E. R., Spooren, P. F. M. J., & Egberts, A. C. G. (2005). Impaired glucose homeostasis after imipramine intake in a diabetic patient [9]. Journal of Clinical Psychopharmacology, 25(6), 621-623. https://doi.org/10.1097/01.jcp.0000186737.76653.57
Van Wijk, B. L. G., Klungel, O. H., Heerdink, E. R., & De Boer, A. (2005). Compliantie, adherentie en persistentie bij antihypertensiva: Apotheker zou therapietrouw moeten bevorderen. Pharmaceutisch Weekblad, 140(48), 1543-1545.
van Wijk, B. L. G., Klungel, O. H., Heerdink, E. R., & De Boer, A. (2005). Rate and determinants of 10-year persistence with antihypertensive drugs. Journal of Hypertension, 23(11), 2101-2107. https://doi.org/10.1097/01.hjh.0000187261.40190.2e
Van Wijk, B. L., Klungel, O. H., Heerdink, E. R., & de Boer, A. (2005). Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Annals of Pharmacotherapy, 39(2), 319-28. https://doi.org/10.1345/aph.1E027
Hugenholtz, G. W. K., Heerdink, E. R., Meijer, W. E. E., Stolker, J. J., Egberts, A. C. G., & Nolen, W. A. (2005). Reasons for Switching between Antipsychotics in Daily Clinical Practice. Pharmacopsychiatry, 38, 122-124.
https://dspace.library.uu.nl/bitstream/handle/1874/11818/hugenholtz_04_reasons_for_switching_between.pdf?sequence=2
Brook, O. H., van Hout, H., Stalman, W. A. B., Nieuwenhuyse, H., Bakker, B., Heerdink, E. R., & de Haan, M. (2005). A Pharmacy-Based Coaching Program to Improve Adherence to Antidepressant Treatment Among Primary Care Patients. Psychiatric Services, 56(4), 487-489.
https://dspace.library.uu.nl/bitstream/handle/1874/11817/heerdink_05_apharmacy_based_coaching_program_to.pdf?sequence=2
Hugenholtz, G. W. K., Heerdink, E. R., van Staa, T. P., Nolen, W. A., & Egberts, A. C. G. (2005). Risk of hip/femur fractures in patients using antipsychotics. Bone, 37, 864-870.
https://dspace.library.uu.nl/bitstream/handle/1874/11844/hugenholtz_05_risk_of_hipfemurfractures.pdf?sequence=2
van Geffen, E. C. G., Hugtenburg, J. G., Heerdink, E. R., Van Hulten, R. P., & Egberts, A. C. G. (2005). Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation. European Journal of Clinical Pharmacology, 61, 303-307.
https://dspace.library.uu.nl/bitstream/handle/1874/11826/geffen_05_discontinuation_symptoms_in_users.pdf?sequence=2
Florentinus, S. R., Nielsen, M. W., van Dijk, L., Leufkens, H. G. M., Hansen, E. H., & Heerdink, E. R. (2005). Patient characteristics associated with prescribing of a newly introduced drug: the case of rofecoxib. European Journal of Clinical Pharmacology, 61, 157-159.
https://dspace.library.uu.nl/bitstream/handle/1874/27409/florentinus_05_patientcharacteristicsassociatedwithprescribing.pdf?sequence=1
Wilting, I., Movig, K. L. L., Moolenaar, M., Hekster, Y. A., Brouwers, J. R. B. J., Heerdink, E. R., Nolen, W. A., & Egberts, A. C. G. (2005). Drug-drug interactions as a determinant of elevated lithium serum levels in daily clinical practice. Bipolar Disorders, 7, 274-280.
https://dspace.library.uu.nl/bitstream/handle/1874/11914/wilting_05_drug_drug_interactionsasadeterminantofelevatedlithium%2520.pdf?sequence=2
Florentinus, S. R., Heerdink, E. R., de Boer, A., van Dijk, L., Leufkens, H. G. M., & de Boer, A. (2005). The trade-off between cardiovascular and gastrointestinal effects of rofecoxib. Pharmacoepidemiology and Drug Safety, 14(7), 437-441. https://doi.org/10.1002/pds.1123
Meijer, W. E. E., Heerdink, E. R., Leufkens, H. G. M., Herings, R. M. C., Egberts, A. C. G., & Nolen, W. A. (2005). Langdurig gebruik van antidepressiva in Nederland in 1991-2001: prevalentie, incidentie en risico-indicatoren*. Nederlands Tijdschrift voor Geneeskunde, 149(13), 708-711.
https://dspace.library.uu.nl/bitstream/handle/1874/11676/meijer_05_langrduriggebruikvanantidepressiva.pdf?sequence=2
Derijks, H. J., de Koning, G. H. P., Meyboom, R. H., Heerdink, E. R., Spooren, P. F. M. J., & Egberts, A. C. G. (2005). Impaired Glucose Homeostasis After Imipramine Intake in a Diabetic Patient. Journal of Clinical Psychopharmacology, 25(6), 621-623.
https://dspace.library.uu.nl/bitstream/handle/1874/11860/Derijks_05_ImpairedGlucoseHomeostasis.pdf?sequence=2
Hugtenburg, J. G., Griekspoor, J. E., de Boer, I., Heerdink, E. R., Tso, Y. H., & Egberts, A. C. G. (2005). Methylphenidate: use in daily practice. Pharmacy World & Science, 27, 197-201.
https://dspace.library.uu.nl/bitstream/handle/1874/11840/hugtenburg_04_methylphenidate_use_in_dailypractice.pdf?sequence=2
Hugtenburg, J. G., Heerdink, E. R., & Tso, Y. H. (2005). Psychoactive drug prescribing by Dutch child and adolescent psychiatrists. Acta Paediatrica, 94, 1484-1487.
https://dspace.library.uu.nl/bitstream/handle/1874/11842/hugtenburg_05_psychoactive_drugprescribing.pdf?sequence=2
Stolk, P., Heerdink, E. R., & Leufkens, H. G. M. (2005). Changes in the defined daily dose; CYP2D6/CYP3A metabolism as an indicator for dose-setting problems. European Journal of Clinical Pharmacology, 61, 243-246.
https://dspace.library.uu.nl/bitstream/handle/1874/11808/stolk_05_changesinthedefineddailydose.pdf?sequence=2
Stuffken, R., Van Hulten, R. P., Heerdink, E. R., Movig, K. L. L., & Egberts, A. C. G. (2005). The impact of hospitalisation on the initiation and long-term use of benzodiazepines. European Journal of Clinical Pharmacology, 61, 291-295.
https://dspace.library.uu.nl/bitstream/handle/1874/11897/stuffken_05_theimpactofhospitalisation.pdf?sequence=2
Stolker, J. J., Hugenholtz, G. W. K., Heerdink, E. R., Nijman, H. L. I., Leufkens, H. G. M., & Nolen, W. A. (2005). Seclusion and the use of antipsychotics in hospitalized psychiatric patients. Psychology, Crime & Law, 11(4), 489-495.
https://dspace.library.uu.nl/bitstream/handle/1874/11811/stolkere_05_seclusionandtheuseofantipsychotics.pdf?sequence=2

Professional publications

Van Wijk, B. L. G., Klungel, O. H., Heerdink, E. R., & De Boer, A. (2005). apothekers en therapietrouw. Pharmaceutisch Weekblad, 140(48), 1543-1545.

Other output

Gardarsdottir, H., Heerdink, E. R., & Egberts, A. C. G. (2005). Potential Bias in Pharmacoepidemiological Studies Due to the Length of the Drug Free Period: A Study on Antidepressant Drug Use in Adults in the Netherlands. S202. Abstract from Unknown event, Asilomar, USA.
Florentinus, S. R., Heerdink, E. R., de Boer, A., van Dijk, L., & Leufkens, H. G. M. (2005). The Trade-Off between Cardiovascular and Gastrointestinal Effects of Rofecoxib. S97. Abstract from Unknown event, Asilomar, USA.
Stolk, P., van Wijk, B. L. G., Heerdink, E. R., & Leufkens, H. G. M. (2005). Variation in Antihypertensive Utilisation and Guideline Preference. S82. Abstract from Unknown event, Asilomar, USA.
Hugenholtz, G. W. K., Heerdink, E. R., Nolen, W. A., & Egberts, A. C. G. (2005). Incidence and Prevalence of Antipsychotic Use in Non-Insitutionalised Patients in 1993-2003. S10. Abstract from Unknown event, Asilomar, USA.
Goedhard, L. E., Stolker, J. J., Heerdink, E. R., Nijman, H. L. I., & Egberts, A. C. G. (2005). The Association between p.r.n. (As-Needed) Medication and Aggressive Incidents in Psychiatric Inpatients. S24. Abstract from Unknown event, Asilomar, USA.
van Wijk, B. L. G., Klungel, O. H., Heerdink, E. R., & de Boer, A. (2005). 10 Year Persistence in Use of Antihypertensive Drugs. S197. Abstract from Unknown event, Asilomar, USA.
van Wijk, B. L. G., Klungel, O. H., Heerdink, E. R., & de Boer, A. (2005). Non-compliance with antihypertensive drugs is associated with discontinuation of antihypertensive drugs.. 137. Abstract from Unknown event, Asilomar, USA.
Fase, S., Wilting, I., Heerdink, E. R., Nolen, W. A., & Egberts, A. C. G. (2005). The Influence of Environmental Temperature on Lithium Serum Levels. S5. Abstract from Unknown event, Asilomar, USA.
van Geffen, E. C. G., Hugtenburg, J. G., Heerdink, E. R., Van Hulten, R. P., & Egberts, A. C. G. (2005). Discontinuation Symptoms in SSRI Users in Clinical Practice: Tapering Versus Abrupt Discontinuation. S130. Abstract from Unknown event, Asilomar, USA.

2004

Scholarly publications

Florentinus, S., Van Dijk, L., De Jong, A., & Heerdink, R. (2004). Relaties tussen farmaceutische industrie en artsen/apothekers: Invloed? Welke invloed? Pharmaceutisch Weekblad, 139(6), 181-185.
Florentinus, S. R., Heerdink, E. R., Klungel, O. H., De Boer, A., Kastelein, J. J. P., Wolfe, S. M., Cohen, J. S., Olsson, G. O., & Fox, J. C. (2004). Should rosuvastatin be withdrawn from the market? [1] (multiple letters). The Lancet HIV, 364(9445), 1577-1580. https://doi.org/10.1016/S0140-6736(04)17301-7
Florentinus, S. R., Heerdink, E. R., Klungel, O. H., & de Boer, A. (2004). Should rosuvastatin be withdrawn from the market? The Lancet, 364(9445), 1577; author reply 1578-9. https://doi.org/10.1016/S0140-6736(04)17301-7
Hugtenburg, J. G., Heerdink, E. R., & Egberts, A. C. G. (2004). Increased psychotropic drug consumption by children in the Netherlands during 1995-2001 is caused by increased use of methylphenidate by boys. European Journal of Clinical Pharmacology, 60, 377-379.
https://dspace.library.uu.nl/bitstream/handle/1874/14962/hugtenburg_04_increased_psychotropic_drugcons.pdf?sequence=1
Stolker, J. J., Heerdink, E. R., Zitman, F. G., & Leufkens, H. G. M. (2004). Correlated measures in longitudinal analysis of daily drug use patterns in a general intensive care unit. Pharmacoepidemiology and Drug Safety, 13, 395-398.
https://dspace.library.uu.nl/bitstream/handle/1874/11810/stolker_04_correlatedmeasuresinlongitudinal.pdf?sequence=2
van Wijk, B. L. G., Klungel, O. H., Heerdink, E. R., & de Boer, A. (2004). The association between compliance with antihypertensive drugs and modification of antihypertensive drug regimen. Journal of Hypertension, 22, 1831-1837.
https://dspace.library.uu.nl/bitstream/handle/1874/11879/boer_04_WijkvanTheAssociationBetweenCompliance.pdf?sequence=2
Heerdink, E. R., Stolker, J. J., Meijer, W. E. E., Hugenholtz, G. W. K., & Egberts, A. C. G. (2004). Need for medicine-based evidence in pharmacotherapy. British Journal of Psychiatry, 184, 452.
https://dspace.library.uu.nl/bitstream/handle/1874/11824/heerdink_04_need_for_medicine_based_evidence.pdf?sequence=2
Stolker, J. J., & Heerdink, E. R. (2004). Better treatment for psychiatric patients avoiding health care: discussion of legislation should not be isolated from other factors and considerations. Nederlands Tijdschrift voor Geneeskunde, 148(30), 1514.
https://dspace.library.uu.nl/bitstream/handle/1874/11809/stolker_04_beterebehandelingvanzorgmijdendepsychiatrischepatient.pdf?sequence=2
Florentinus, S. R., Heerdink, E. R., Klungel, O. H., & de Boer, A. (2004). Should rosuvastatin be withdrawn from the market? The Lancet, 364, 1577-1580.
https://dspace.library.uu.nl/bitstream/handle/1874/11893/boer_04_FlorentinusShouldRosuvastatinBeWithdrawn.pdf?sequence=2
Meijer, W. E. E., Heerdink, E. R., Nolen, W. A., Herings, R. M. C., Leufkens, H. G. M., & Egberts, A. C. G. (2004). Association of Risk of Abnormal Bleeding With Degree of Serotonin Reuptake Inhibition by Antidepressants. Archives of Internal Medicine, 164, 2364-2370.
https://dspace.library.uu.nl/bitstream/handle/1874/11674/meijer_04_associationofriskofabnormalbleeding.pdf?sequence=2
Hugenholtz, G. W. K., Heerdink, E. R., Nolen, W. A., & Egberts, A. C. G. (2004). Less medication switching after initial start with atypical antipsychotics. European Neuropsychopharmacology, 14, 1-5.
https://dspace.library.uu.nl/bitstream/handle/1874/11816/hugenholtz_04_less_medication_switchingafterstart.pdf?sequence=2
Meijer, W. E. E., Heerdink, E. R., Leufkens, H. G. M., Herings, R. M. C., Egberts, A. C. G., & Nolen, W. A. (2004). Incidence and determinants of long-term use of antidepressants. European Journal of Clinical Pharmacology, 60, 57-61.
https://dspace.library.uu.nl/bitstream/handle/1874/11675/meijer_04_incidenceanddeterminants.pdf?sequence=2

Professional publications

Hugtenburg, J. G., Faber, A., Schirm, E., de Boer, I., Tobi, H., Heerdink, E. R., & Tso, Y. H. (2004). Methylfenidaat bij kinderen: gebruik en ervaringen in Nederland. Tijdschrift voor Psychiatrie, 46(1), 31-37.
https://dspace.library.uu.nl/bitstream/handle/1874/11822/hugtenburg_04_methylfenidaat_bij_kinderen.pdf?sequence=2
Hugenholtz, G. W. K., Kok, R. M., Meijer, W. E. E., Urquhart, J., & Heerdink, E. R. (2004). Ernstige intoxicatie door therapietrouw. Pharmaceutisch Weekblad, 139(23), 803.
https://dspace.library.uu.nl/bitstream/handle/1874/11835/hugenholtz_04_ernstige_intoxicatiedoor.pdf?sequence=2
Wilting, I., Heerdink, E. R., Egberts, A. C. G., & Nolen, W. A. (2004). Therapeutische voor- en nadelen van lithium. Elementaire behandeling van bipolaire stoornis. Pharmaceutisch Weekblad, 10(139), 328-322.
https://dspace.library.uu.nl/bitstream/handle/1874/11913/wilting_04_elementairebehandelinglithiumpw.pdf?sequence=2
Hugtenburg, J. G., Griekspoor, J. E., Heerdink, E. R., & Tso, Y. H. (2004). Onderzoek naar de therapietrouw bij het gebruik van methylfenidaat door kinderen. Tijdschrift voor Psychiatrie, 46(1), 7-14.
https://dspace.library.uu.nl/bitstream/handle/1874/11827/hugtenburg_04_onderzoek_naar_de_therapietrouw.pdf?sequence=2
Florentinus, S. R., van Dijk, L., de Jong, A., & Heerdink, E. R. (2004). Relatie tussen farmaceutische industrie en artsen/apothekers. Invloed? Welke invloed? Pharmaceutisch Weekblad, 139(6), 180-185.
https://dspace.library.uu.nl/bitstream/handle/1874/11846/florentinus_04_invloedwelkeinvloed.pdf?sequence=2

Other output

van Wijk, B. L. G., Klungel, O. H., Heerdink, E. R., & de Boer, A. (2004). Comparison of Different Methods To Calculate Persistance of Drug Use by Using Pharmacy Records. S44. Abstract from Unknown event, Asilomar, USA.
Hugenholtz, G. W. K., Heerdink, E. R., Nolen, W. A., & Egberts, A. C. G. (2004). Acute and Long-Term Risk of Femur Fractures in Patients on Antipsychotics. S21. Abstract from Unknown event, Asilomar, USA.
Hugtenburg, J. G., Heerdink, E. R., & Egberts, A. C. G. (2004). Drug Prescribing by Dutch Child and Adolescent Psychiatrists. S95. Abstract from Unknown event, Asilomar, USA.
van Wijk, B. L. G., Klungel, O. H., Heerdink, E. R., & de Boer, A. (2004). Non-Compliance with Antihypertensive Drugs Is Associated with Discontinuation of Antihypertensive Drugs. S47. Abstract from Unknown event, Asilomar, USA.
Stolk, P., Heerdink, E. R., Urquhart, J., & Leufkens, H. G. M. (2004). Defined Daily Dose (DDD) Changes Are Associated with Drug Metabolism through CYP450. S109. Abstract from Unknown event, Asilomar, USA.

2003

Scholarly publications

Heerdink, R. (2003). Meldingen. Pharmaceutisch Weekblad, 138(16), 541.
Heerdink, R. (2003). 'Evidence'. Pharmaceutisch Weekblad, 138(21), 729.
Bouvy, M. L., Heerdink, E. R., Urquhart, J., Grobbee, D. E., Hoes, A. W., & Leufkens, H. G. M. (2003). Apotheker stimuleert correct gebruik lisdiuretica bij patiënten met hartfalen: Begeleiding verbetert therapietrouw. Pharmaceutisch Weekblad, 138(41), 1432-1439.
Heerdink, E. R., Hugenholtz, G. W. K., Meijer, W. E. E., & Egberts, A. C. G. (2003). Channelling new antidepressants to problem patients may be factor in fatal toxicity [5]. British Medical Journal, 326(7389).
Bouvy, M. L., Heerdink, E. R., Leufkens, H. G. M., & Hoes, A. W. (2003). Patterns of pharmacotherapy in patients hospitalised for congestive heart failure. European Journal of Heart Failure, 5, 195-200.
https://dspace.library.uu.nl/bitstream/handle/1874/27414/bouvy_03_patternsofpharmacotherapyin.pdf?sequence=1
Stolker, J. J., Hugenholtz, G. W. K., Heerdink, E. R., Nijman, HLI., Leufkens, H. G. M., & Nolen, W. A. (2003). Separatie van opgenomen psychotische patiënten: later bij gebruik van antipsychotica en mogelijk ook minder vaak. Nederlands Tijdschrift voor Geneeskunde, 147(12), 557-561.
https://dspace.library.uu.nl/bitstream/handle/1874/27526/stolker_03_separatieophenomenpsychiatrischepatienten.pdf?sequence=2
Bouvy, M. L., Heerdink, E. R., Leufkens, H. G. M., & Hoes, A. W. (2003). Predicting mortality in patients with heart failure: a pragmatic approach. Heart, 89, 605-609.
https://dspace.library.uu.nl/bitstream/handle/1874/27410/bouvy_03_predictingmortalityinpatientswithheartfailure.pdf?sequence=1
Hugenholtz, G. W. K., Stolker, J. J., Heerdink, E. R., Nolen, W. A., & Leufkens, H. G. M. (2003). Short-acting parenteral antipsychotics drive choice for classical versus atypical agents. European Journal of Clinical Pharmacology, 58(11), 757-760.
https://dspace.library.uu.nl/bitstream/handle/1874/27483/hugenholtz_03_shortactingantipsychoticsdrivechoice.pdf?sequence=1
Bouvy, M. L., Heerdink, E. R., Urquhart, J., Grobbee, D. E., Hoes, A. W., & Leufkens, H. G. M. (2003). Effect of a Pharmacist-Led Intervention on Diuretic Compliance in Heart Failure Patients: A Randomized Controlled Study. Journal of Cardiac Failure, 9(5), 404-410.
https://dspace.library.uu.nl/bitstream/handle/1874/27435/bouvy_03_effectofapharmacistledintervention.pdf?sequence=1
Brook, O., Hout, H., Nieuwenhuyse, H., & Heerdink, E. R. (2003). Impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients; a randomized controlled trial. European Neuropsychopharmacology, 13, 1-9.
https://dspace.library.uu.nl/bitstream/handle/1874/27507/heerdink_03_impactofcoachingbycommunitypharmacists.pdf?sequence=1
Heerdink, E. R., Hugenholtz, G. W. K., Meijer, W. E. E., & Egberts, A. C. G. (2003). Channeling new antidepressants to problem patients may be factor in fatal toxicity. BMJ (International edition), 326, 600.
https://dspace.library.uu.nl/bitstream/handle/1874/17394/heerdink_03_channeling.pdf?sequence=1
Spoelstra, J. A., Stolk, R. P., Heerdink, E. R., Klungel, O. H., Erkens, J. A., Leufkens, H. G. M., & Grobbee, D. E. (2003). Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy. Pharmacoepidemiology and Drug Safety, 12, 121-127.
https://dspace.library.uu.nl/bitstream/handle/1874/27484/spoelstra_03_refillcomplianceintype2diabetesmellitus.pdf?sequence=2
Stolker, J. J., Hugenholtz, G. W. K., Heerdink, E. R., Nijman, H. L., Leufkens, H. G. M., & Nolen, W. A. (2003). Seclusion of admitted psychotic patients: later in the case of antipsychotic. Nederlands Tijdschrift voor Geneeskunde, 147(12), 557-561.
Bouvy, M. L., Heerdink, E. R., Hoes, A. W., & Leufkens, H. G. M. (2003). Effects of NSAIDs on the Incidence of Hospitalisations for Renal Dysfunction in Users of ACE Inhibitors. Drug Safety, 26(13), 983-989.
https://dspace.library.uu.nl/bitstream/handle/1874/27440/bouvy_03_effectsofnsaidsontheincidende.pdf?sequence=1

Professional publications

Stolker, J. J., Koedoot, P. J., Heerdink, E. R., Leufkens, H. G. M., & Nolen, W. A. (2003). Het psychofarmacagebruik door verstandelijk gehandicapte bewoners van gezinsvervangende tehuizen. Tijdschrift voor Psychiatrie, 45(11), 667-675.
https://dspace.library.uu.nl/bitstream/handle/1874/29426/stolker_03_hetpsychofarmacagebruikdoorverstandelijkgehandicapteb.pdf?sequence=2
Bouvy, M. L., Heerdink, E. R., Urquhart, J., Grobbee, D. E., Hoes, A. W., & Leufkens, H. G. M. (2003). Begeleiding verbetert therapietrouw. Apotheker stimuleert correct gebruik lisdiuretica bij patiënten met hartfalen. Pharmaceutisch Weekblad, 138(41), 1432-1439.
https://dspace.library.uu.nl/bitstream/handle/1874/27428/bouvy_03_begeleidingverbeterttherapietrouw.pdf?sequence=1
van Dijk, L., Florentinus, S. R., de Jong, A., Velthove, K. J., Heerdink, E. R., & Kallewaard, M. (2003). Het voorschrijven van nieuwe geneesmiddelen in de huisartspraktijk: voorschrijfvolume en off-label voorschrijven. NIVEL.
https://dspace.library.uu.nl/bitstream/handle/1874/29441/dijk_03_voorschrijven%2520-%2520off-label-voorschrijven.pdf?sequence=3
Faber, A., Hugtenburg, J. G., Schirm, E., de Boer, I., Tobi, H., & Heerdink, E. R. (2003). Gebruik door Nederlandse kinderen en ervaringen van ouders. Methylfenidaat rukt onstuitbaar op. Pharmaceutisch Weekblad, 138(11), 374-378.
https://dspace.library.uu.nl/bitstream/handle/1874/27516/hugtenburg_03_methylfenidaatruktonstuitbaarop.pdf?sequence=1
Stolker, J. J., & Heerdink, E. R. (2003). De kloof tussen de psychiatrische praktijk en 'evidence-based medicine'. Databases om bruggen te slaan. Pharmaceutisch Weekblad, 138(8), 271-274.
https://dspace.library.uu.nl/bitstream/handle/1874/27529/stolker_03_databasesombruggenteslaan.pdf?sequence=2

Other output

Meijer, W. E. E., Heerdink, E. R., Nolen, W. A., Leufkens, H. G. M., & Egberts, A. C. G. (2003). Risk of Abnormal Bleeding Associated with Use of Serotonin Reuptake Inhibitors. S98. Abstract from Unknown event, Asilomar, USA.
Florentinus, S. R., Velthove, K. J., van Dijk, L., & Heerdink, E. R. (2003). Determinants of Off-Label Rofecoxib Prescribing by General Physicians. S32. Abstract from Unknown event, Asilomar, USA.
Hugenholtz, G. W. K., Meijer, W. E. E., Stolker, J. J., Heerdink, E. R., Nolen, W. A., & Egberts, A. C. G. (2003). Reasons for Switching between Antipsychotics. S111-S112. Abstract from Unknown event, Asilomar, USA.
Hugtenburg, J. G., Witte, I., & Heerdink, E. R. (2003). Compliance with Methylphenidate in Children as Reported by Parents. S5-S6. Abstract from Unknown event, Asilomar, USA.

2002

Scholarly publications

Heerdink, E. R. (2002). Polyfarmacie bij ouderen in Nederland. Pharmaceutisch Weekblad, 137(36), 1257-1259.
Heerdink, R. (2002). De rampen van het geneesmiddelengebruik. Pharmaceutisch Weekblad, 137(17), 593.
Movig, K. L. L., Meijer, W. E. E., Heerdink, E. R., Leufkens, H. G. M., Egberts, A. C. G., Sewnath, M. E., & Gouma, D. J. (2002). Toegenomen peroperatief bloedverlies bij paroxetinegebruik. Nederlands Tijdschrift voor Geneeskunde, 146(52), 2564-2565.
Meijer, W. E. E., Heerdink, E. R., Egberts, A. C. G., Leufkens, H. G. M., & Waldinger, M. D. (2002). Is sexual dysfunctioning a reason for discontinuation in users of selective serotonin reuptake inhibitors? [5]. Journal of Clinical Psychopharmacology, 22(1), 96-98. https://doi.org/10.1097/00004714-200202000-00019
Bouvy, M. L., Heerdink, E. R., Hoes, A. W., & Leufkens, H. G. M. (2002). Amiodarone-induced thyroid dysfunction associated with cumulative dose. Pharmacoepidemiology and Drug Safety, 11, 601-606.
https://dspace.library.uu.nl/bitstream/handle/1874/29350/bouvy_02_amiodaroneinducedthyroiddisfunction.pdf?sequence=1
Feenstra, J., Heerdink, E. R., Grobbee, D. E., & Stricker, B. H. C. (2002). Association of Nonsteroidal Anti-inflammatory Drugs With First Occurence of Heart Failure and With Relapsing Heart Failure. Archives of Internal Medicine, 162, 265-270.
https://dspace.library.uu.nl/bitstream/handle/1874/27891/heerdink_02_associationofnonsteroidalantiinflammatorydrugs.pdf?sequence=1
Claessens, A. A. M. C., Heerdink, E. R., van Eijk, J. T., Lamers, C. B., & Leufkens, H. G. M. (2002). Deteminants of headache in lansoprazole users in The Netherlands: results from a nested case-control study. Drug Safety, 25(4), 287-295.
https://dspace.library.uu.nl/bitstream/handle/1874/27866/claessens_02_determinantsofheadache.pdf?sequence=1
Stolker, J. J., Koedoot, P. J., Heerdink, E. R., Leufkens, H. G. M., & Nolen, W. A. (2002). Psychotropic drug use in intellectually disabled group-home residents with behavioural problems. Pharmacopsychiatry, 35, 19-23.
https://dspace.library.uu.nl/bitstream/handle/1874/27875/stolker_02_psychotropicdruguseinintellectuallydisabled.pdf?sequence=2
Meijer, W. E. E., Heerdink, E. R., van Eijk, J. T., & Leufkens, H. G. M. (2002). Adverse events in users of sertraline: results from an observational study in psychiatric practice in the Netherlands. Pharmacoepidemiology and Drug Safety, 11, 655-662.
https://dspace.library.uu.nl/bitstream/handle/1874/27984/meijer_02_adverseeventsinusersofsertraline.pdf?sequence=2
Claessens, A. A. M. C., Heerdink, E. R., van Eijk, J. T., Lamers, C. B. H. W., & Leufkens, H. G. M. (2002). Characteristics of diarrhoea in 10 008 users of lansoprazole in daily practice: which co-factors contribute? Pharmacoepidemiology and Drug Safety, 11, 703-708.
https://dspace.library.uu.nl/bitstream/handle/1874/29348/claessens_02_characteristicsofdiarrhoea.pdf?sequence=1
Heerdink, E. R., Urquhart, J., & Leufkens, H. G. M. (2002). Changes in prescribed drug doses after market introduction. Pharmacoepidemiology and Drug Safety, 11, 447-453.
https://dspace.library.uu.nl/bitstream/handle/1874/29399/heerdink_02_changesinprescibeddrugdosisaftermarketintroduction.pdf?sequence=1
Meijer, W. E. E., Heerdink, E. R., Egberts, A. C. G., Leufkens, H. G. M., & Waldinger, M. D. (2002). Is sexual dysfunctioning a reason for discontinuation in users of selective serotonin reutake inhibitors? Journal of Clinical Psychopharmacology, 22(1), 96-98.
Stolker, J. J., Meijer, W. E. E., Hugenholtz, G. W. K., Nolen, W. A., & Heerdink, E. R. (2002). Farmaco-epidemiologisch onderzoek in de psychiatrie. Tijdschrift voor Psychiatrie, 44(4), 275-280.
https://dspace.library.uu.nl/bitstream/handle/1874/29383/stolker_02_farmacoepidemiologieonderzoekindepsychiatrie.pdf?sequence=2

Professional publications

Hugenholtz, G. W. K., Heerdink, E. R., Stolker, J. J., Nolen, W. A., & Leufkens, H. G. M. (2002). De keus tussen klassiek en atypisch; antipsychotica voor nieuw-opgenomen psychiatrische patiénten. Pharmaceutisch Weekblad, 137, 738-741.
https://dspace.library.uu.nl/bitstream/handle/1874/27874/hugenholtz_02_antipsychoticavoornieuwopgenomenpsychiatrischepat.pdf?sequence=1
Heerdink, E. R. (2002). Polyfarmacie bij ouderen in Nederland. Een overzicht van beschikbare gegevens. Pharmaceutisch Weekblad, 137(36), 1257-1259.
https://dspace.library.uu.nl/bitstream/handle/1874/27871/heerdink_02_eenoverzichtvanbeschikbaregegevenspolyfamacie.pdf?sequence=1
Hugenholtz, G. W. K., Heerdink, E. R., Stolker, J. J., Nolen, W. A., & Leufkens, H. G. M. (2002). Antipsychotica voor nieuw opgenomen psychiatrische patienten. De keus tussen klassiek en atypisch. Pharmaceutisch Weekblad, 137, 738-741.

Other output

Bouvy, M. L., Heerdink, E. R., Hoes, A. W., & Leufkens, H. G. M. (2002). Start of NSAIDs increases the risk of renal dysfunction in users of ACE inhibitors. S123-S123. Abstract from Unknown event, Asilomar, USA.
Spoelstra, J. A., Stolk, R. P., Heerdink, E. R., Klungel, O. H., Erkens, J. A., Leufkens, H. G. M., & Grobbee, D. E. (2002). Refill compliance in type 2 diabetes mellitus: A predictor of switching to insuline therapy?. S16-S16. Abstract from Unknown event, Asilomar, USA.
Hugenholtz, G. W. K., Heerdink, E. R., Nolen, W. A., & Leufkens, H. G. M. (2002). Less switching after initial start with atypical antipsychotics. S97-S97. Abstract from Unknown event, Asilomar, USA.
Meijer, W. E. E., Heerdink, E. R., Nolen, W. A., & Leufkens, H. G. M. (2002). Early discontinuation and long-term therapy in new SSRI users. S156-S157. Abstract from Unknown event, Asilomar, USA.
Hugtenburg, J. G., Heerdink, E. R., de Boer, I., & Tso, Y. H. (2002). Use effectiveness and side effects of methylphenidate in children as reported by parents. S176-S176. Abstract from Unknown event, Asilomar, USA.

2001

Scholarly publications

Heerdink, E. R., Leufkens, H. G. M., Claessens, A. A. M. C., Lamers, C. B. H. W., & Van Eijk, J. T. M. (2001). Factors associated with non-response in proton pump inhibitor users: A study of lansoprazole therapy. Pharmacy World and Science, 23(3), 107-110. https://doi.org/10.1023/A:1011279426224
Dessing, W. S., Heerdink, E. R., & Hudson, S. A. (2001). Evidence-based behandeling van hartfalen: De nederlandse en de Schotse standaarden. Pharmaceutisch Weekblad, 136(15), 546-547.
Williams, C., Bouvy, M. L., Heerdink, E. R., De Bruin, M. L., Herings, R. M. C., Leufkens, H. G. M., & Hoes, A. W. (2001). Baseline rates of disease may account for some arrhythmia risk [3] (multiple letters). Archives of Internal Medicine, 161(9), 1235-1236. https://doi.org/10.1001/archinte.161.9.1235
Meijer, W. E. E., Heerdink, E. R., Pepplinkhuizen, L. P., van Eijk, J. T., & Leufkens, H. G. M. (2001). Prescribing patterns in patients using new antidepressants. British Journal of Clinical Pharmacology, 51, 181-183.
https://dspace.library.uu.nl/bitstream/handle/1874/27903/meijer_01_prescribingpatternsinpatients.pdf?sequence=2
Bouvy, M. L., Heerdink, E. R., Leufkens, H. G. M., & Hoes, A. W. (2001). Amiodarone induced thyreoid-dysfunction. S75-S76. Abstract from Unknown event, Asilomar, USA.
Claessens, A. A. M. C., Heerdink, E. R., Lamers, C. B., van Eijk, J. T., & Leufkens, H. G. M. (2001). Factors associated with non-response in proton punp inhibitor users: a study of lansoprazole therapy. Pharmacy World & Science, jun(23(3)), 107-110.
https://dspace.library.uu.nl/bitstream/handle/1874/27863/claessens_01_factorsassociatedwithnonresponse.pdf?sequence=1
Bouvy, M. L., Heerdink, E. R., de Bruin, M. L., Herings, R. M. C., Leufkens, H. G. M., & Hoes, A. W. (2001). Baseline Rates of Disease May Account for Some Arrhythmia Risk. Archives of Internal Medicine, 161, 1235-1236.
Meijer, W. E. E., Bouvy, M. L., Heerdink, E. R., Urquhart, J., & Leufkens, H. G. M. (2001). Spontaneous lapses in dosing during chronic treatment with selective serotonin reuptake inhibitors. British Journal of Psychiatry, 179, 519-522.
https://dspace.library.uu.nl/bitstream/handle/1874/27961/meijer_01_spontaneouslapsesindosing.pdf?sequence=2
Stolker, J. J., Heerdink, E. R., Leufkens, H. G. M., Clerkx, M. G. M., & Nolen, W. A. (2001). Determinants of multiple psychotropic drug use in patients with mild intellectual disabilities or borderline intellectual functioning and psychiatric or behavioral disorders. General Hospital Psychiatry, 23, 345-349.
https://dspace.library.uu.nl/bitstream/handle/1874/27980/stolker_01_determinantsofmultiplepsychotropicdruguse.pdf?sequence=2
Bouvy, M. L., Heerdink, E. R., & Herings, R. M. C. (2001). Long term therapy with spironolactone. Pharmacy World & Science, 23(4), 132-134.
https://dspace.library.uu.nl/bitstream/handle/1874/27810/bouvy_01_longtermtherapywithspironolactone.pdf?sequence=1

Other output

Meijer, W. E. E., Bouvy, M. L., Heerdink, E. R., Urquhart, J., & Leufkens, H. G. M. (2001). Spontaneous lapses in dosing during chronic treatment with antidepressant drugs. S77-S77. Abstract from Unknown event, Asilomar, USA.
Meijer, W. E. E., Heerdink, E. R., van Eijk, J. T., & Leufkens, H. G. M. (2001). Underreporting of adverse drug reactions (ADRS) in elderly patients using SSRIs?. S79-S79. Abstract from Unknown event, Asilomar, USA.
Stolker, J. J., Hugenholtz, G. W. K., Heerdink, E. R., Nijman, HLI., Leufkens, H. G. M., & Nolen, W. A. (2001). Delay of Antipsychotic Treatment Leads to Seclusion in Psychiatric Inpatients. S107. Abstract from Unknown event, Asilomar, USA.
Hugtenburg, J. G., Themen, I., & Heerdink, E. R. (2001). Prevelance of psychoactive and anti-epileptic drugs consumption by children in the Netherlands. S116-S116. Abstract from Unknown event, Asilomar, USA.
Hugenholtz, G. W. K., Stolker, J. J., Heerdink, E. R., Nolen, W. A., & Leufkens, H. G. M. (2001). Initial antipsychotic treatment in hospitalised psychiatric patients. S118-S118. Abstract from Unknown event, Asilomar, USA.
Klungel, O. H., Heerdink, E. R., Jones, J. K., Urquhart, J., & Leufkens, H. G. M. (2001). Assessing discontinuation of antihypertensive drug therapies its causes and potential solutions. S74-S74. Abstract from Unknown event, Asilomar, USA.

2000

Scholarly publications

Bouvy, M. L., Stuurman-Bieze, A. G. G., Vervloet, E., Van Wisse, M. W., & Heerdink, E. R. (2000). Farmacotherapie bij angina pectoris: De ongelijke behandeling van mannen en vrouwen. Pharmaceutisch Weekblad, 135(21), 746-751.
Claessens, A. A. M. C., Heerdink, E. R., van Eijk, J. T., Lamers, C. B. H. W., & Leufkens, H. G. M. (2000). Safety Review in 10,008 Users of Lansoprazole in Daily Practice. Pharmacoepidemiology and Drug Safety, 9, 383-391.
https://dspace.library.uu.nl/bitstream/handle/1874/27757/claessens_00_safetyreviewin10008usersoflansoprazole.pdf?sequence=1
van Puijenbroek, E. P., Egberts, A. C. G., Heerdink, E. R., & Leufkens, H. G. M. (2000). Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs. European Journal of Clinical Pharmacology, 56, 733-738.
Bouvy, M. L., Heerdink, E. R., de Bruin, M. L., Herings, R. M. C., Leufkens, H. G. M., & Hoes, A. W. (2000). Use of Sympathomimetic Drugs Leads to Increased Risk of Hospitalization for Arrhythmias in Patients With Congestive Heart Failure. Archives of Internal Medicine, 160(september,), 2477-2480.
https://dspace.library.uu.nl/bitstream/handle/1874/27754/bouvy_00_useofsympathomimeticdrugsLeadsto.pdf?sequence=1
Claessens, A. A. M. C., Heerdink, E. R., van Eijk, J. T., Lamers, C. B. H. W., & Leufkens, H. G. M. (2000). Continued use of the proton-pump inhibitor lansoprazole following Helicobacter pylori eradication. European Journal of Clinical Pharmacology, 55, 773-776.
https://dspace.library.uu.nl/bitstream/handle/1874/27750/claessens_00_continueduseoftheprotonpumpinhibitor.pdf?sequence=1

Professional publications

Bouvy, M. L., & Heerdink, E. R. (2000). Opsporen van verborgen hartfalen. Pharmaceutisch Weekblad, 135(36).

Other output

Bouvy, M. L., Heerdink, E. R., Herings, R. M. C., & Leufkens, H. G. M. (2000). Long term therapy with spironolactone might be difficult to achieve. S30-S30. Abstract from Unknown event, Asilomar, USA.
Meijer, W. E. E., Heerdink, E. R., Pepplinkhuizen, L., van Eijk, J. T., & Leufkens, H. G. M. (2000). Safety profile of new antidepressants. S105-S105. Abstract from Unknown event, Asilomar, USA.
Stolker, J. J., Koedoot, P. J., Heerdink, E. R., Leufkens, H. G. M., & Nolen, W. A. (2000). Psychotropic drug use in mentally retarded group home residents with behavioural problems. S107-S107. Abstract from Unknown event, Asilomar, USA.
Stolker, J. J., Heerdink, E. R., Leufkens, H. G. M., Clerkx, M. G. M., & Nolen, W. A. (2000). Determinants of multiple psychotropic drug usage in a unit for intellectually disabled patients with challeging behaviour. S108-S108. Abstract from Unknown event, Asilomar, USA.
Meijer, W. E. E., Bouvy, M. L., Heerdink, E. R., Urquhart, J., & Leufkens, H. G. M. (2000). The incidence and duration of missed doses during SSRI treatment. S96-S96. Abstract from Unknown event, Asilomar, USA.

1999

Scholarly publications

Bouvy, M. L., Heerdink, E. R., Klungel, O. H., De Boer, A., Stuurman-Bieze, A. G. G., & Leufkens, H. G. (1999). Women with angina pectoris receive less antiplatelet treatment than men. British Journal of General Practice, 49(441), 299-300.
Bouvy, M. L., Heerdink, E. R., Klungel, O. H., de Boer, A., Stuurman-Bieze, A. G. G., & Leufkens, H. G. M. (1999). Women with angina pectoris receive less antiplatelet treatment then men. British Journal of General Practice, 49, 299-300.
van Hulten, R., Heerdink, E. R., Bakker, A., & Leufkens, H. G. M. (1999). Benzodiazepine Pathways in the Chronically III. Pharmacoepidemiology and Drug Safety, 8, 325-330.

Professional publications

Bouvy, M. L., & Heerdink, E. R. (1999). Praktische tips voor de verbetering van de farmacotherapie bij hartfalen: Het begint met het opsporen. Pharmaceutisch Weekblad, 134(22), 764-766.

Other output

Meijer, W. E. E., Heerdink, E. R., Egberts, A. C. G., Waldinger, M. D., & Leufkens, H. G. M. (1999). Sexual dysfunctioning in users of Selective Serotonin Reuptake Inhibitors (SSRIs). S1-S1. Abstract from Unknown event, Asilomar, USA.
Bouvy, M. L., Heerdink, E. R., Herings, R. M. C., Leufkens, H. G. M., & Hoes, A. W. (1999). Hypokaliemic Medication Leads to increased Risk of Hospitalization for Arrhythmias in Patients with CHF. S173-S173. Abstract from Unknown event, Asilomar, USA.
Meijer, W. E. E., Heerdink, E. R., van Eijk, J. T., Pepplinkhuizen, L., & Leufkens, H. G. M. (1999). Discontinuation patterns in patients using new antidepressants. S1-S1. Abstract from Unknown event, Asilomar, USA.

1998

Scholarly publications

Stolker, J. J., Heerdink, E. R., Pullen, S. E. J., Santman, F. W., Hekster, Y. A., Leufkens, H. G. M., & Zitman, F. G. (1998). Determinants of psychotropic drug usage in a general intensive care unit. General Hospital Psychiatry, 20, 371-376.
Heerdink, E. R., Leufkens, H. G. M., Herings, R. M. C., Ottervanger, J. P., Stricker, B. H. C., & Bakker, A. (1998). NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Archives of Internal Medicine, 158, 1108-1108.
Natsch, S., Hekster, Y. A., Heerdink, E. R., Herings, R. M. C., & van der Meer, J. W. M. (1998). Application of the ATC/DDD Methodology to Monitor Antibiotic Drug Use. European Journal of Clinical Microbiology & Infectious Diseases, 17, 20-24.

Professional publications

Bouvy, M. L., & Heerdink, E. R. (1998). SMART PHARMACIST. Pharmaceutisch Weekblad, 133(46).
Egberts, A. C. G., Stuijt, C. C. M., Heerdink, E. R., & Leufkens, H. G. M. (1998). Antidepressiva' als naam aan herziening toe. Pharmaceutisch Weekblad, 133, 776-780.

Other output

Claessens, A. A. M. C., Heerdink, E. R., Lamers, C. B. H. W., & Leufkens, H. G. M. (1998). Which Co-factors are Associated with Non-response in Users of Proton Pump Inhibitors?. S168-S168. Abstract from Unknown event, Asilomar, USA.
Meijer, W. E. E., Heerdink, E. R., van Eijk, J. T., Pepplinkhuizen, L., & Leufkens, H. G. M. (1998). Clustering of symptoms and diagnoses of patients treated with new antidepressants. S170-S170. Abstract from Unknown event, Asilomar, USA.
Meijer, W. E. E., Heerdink, E. R., Pepplinkhuizen, L., van Eijk, J. T., & Leufkens, H. G. M. (1998). Time on market of selective serotonin reuptake inhibitors (SSRIs) Associated with Indication and Comorbidity. S171-S171. Abstract from Unknown event, Asilomar, USA.
Bouvy, M. L., Heerdink, E. R., & Stuurman-Bieze, A. G. G. (1998). Therapy in patients with angina pectoris. Lack of nitrate-free period. S175-S175. Abstract from Unknown event, Asilomar, USA.
Claessens, A. A. M. C., Heerdink, E. R., van Eijk, J. T., Lamers, C. B. H. W., & Leufkens, H. G. M. (1998). Continued PPI treatment after Helicobacter pylori eradication therapies. S168-S168. Abstract from Unknown event, Asilomar, USA.
Bouvy, M. L., Heerdink, E. R., Klungel, O. H., de Boer, A., & Leufkens, H. G. M. (1998). Women with angina pectoris receive less anti-platelet treatment than men. S176-S176. Abstract from Unknown event, Asilomar, USA.

1997

Scholarly publications

Leufkens, H. G. M., Claessens, A. A. M. C., Heerdink, E. R., van Eijk, J. T., & Lamers, C. B. H. W. (1997). A prospective follow-up study in 5,669 users of lansoprazole in daily practice. Alimentary Pharmacology & Therapeutics, 11, 887-897.

Professional publications

Hekster, Y. A., Natsch, S., Heerdink, E. R., & Herings, R. M. C. (1997). Farmaco-epidemiologie van antimicrobiële middelen. Bijblijven, 13, 15-23.

Other output

Claessens, A. A. M. C., Heerdink, E. R., Leufkens, H. G. M., van Eijk, J. T., & Lamers, C. B. H. W. (1997). A population-based prospective follow-up study in 5669 users of lansoprazole. S16-S16. Abstract from Unknown event, Asilomar, USA.
Claessens, A. A. M. C., Heerdink, E. R., van Eijk, J. T., Lamers, C. B. H. W., & Leufkens, H. G. M. (1997). The incidence and characteristics of headache in 5669 users of lansoprazole in daily clinical practice. S17-S17. Abstract from Unknown event, Asilomar, USA.

1996

Other output

Heerdink, E. R., Herings, R. M. C., Leufkens, H. G. M., & Bakker, A. (1996). Multiple Chronic Disease in a Cohort of Elderly Patients; A 5-Year Population-Based Follow-Up Study. S97-S97. Abstract from Unknown event, Asilomar, USA.
Heerdink, E. R., Leufkens, H. G. M., Herings, R. M. C., Ottervanger, J. P., Stricker, B. H. C., & Bakker, A. (1996). Concomitant Use of Diuretics and NSAIDs and the Incidence of Congestive Heart Failure in Time. S98-S98. Abstract from Unknown event, Asilomar, USA.
Heerdink, E. R., Leufkens, H. G. M., Van Gilst, W. H., & Porsius, A. J. (1996). Evaluation of Safety of Last-Line Therapy with Ibopamine. S99-S99. Abstract from Unknown event, Asilomar, USA.

1995

Scholarly publications

Heerdink, E. R., Leufkens, H. G., Koppedraaijer, C., & Bakker, A. (1995). Information on drug use in the elderly: A comparison of pharmacy, general- practitioner and patient data. Pharmacy World & Science, 17(1), 20-24. https://doi.org/10.1007/BF01875554
Veninga, C. C. M., Denig, P., Haaijer-Ruskamp, F. M., Dijkers, F. W., Meyboom-de Jong, B., de Vries, C. S., Timmer, J. W., de Jong-van den Berg, L., van Eijk, M. E. C., de Boer, A., van Hemert, T. J. E., van der Horn, J. A., Steerneman, A. G. M., de Jong-van den Berg, L. T. W., de Wit, M. E. C., Stricker, B. H. C., Porsius, A. J., Peters, E. T. J., van der Werf, G. T., ... Stewart, R. (1995). Abstracts of papers and posters. Pharmacy World & Science, 17(9), 3-7. https://doi.org/10.1007/BF01901737

1993

Scholarly publications

Herings, R. M. C., Heerdink, E. R., & Bakker, A. (1993). OUDEREN EN GECOMBINEERD GEBRUIK VAN GENEESMIDDELEN. Pharmaceutisch Weekblad, 128(49), 1498-1500.
Heerdink, E. R., & Leufkens, H. G. (1993). COMPRESSIE EN CLUSTERING VAN GENEESMIDDELENGEBRUIK BIJ OUDEREN. Pharmaceutisch Weekblad, 128(49), 1492-1497.

1992

Scholarly publications

Heerdink, E. R. (1992). ESCP-SYMPOSIUM 'QUALITY IN PHARMACOTHERAPY'. Pharmaceutisch Weekblad, 127(51-52), 1358-1359.

1991

Scholarly publications

Petri, H., Heerdink, R., Leufkens, H. G., Kessels, F., & Urquhart, J. (1991). Channeling of antidepressant drugs to patients with cardiovascular disease. Post Marketing Surveillance, 5(2), 159-167.